OriginClear (OCLN) 10-K 21 May 21 2020 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2020	May 20, 2021	Jun. 30, 2020
Document Information Line Items
Entity Registrant Name	ORIGINCLEAR, INC.
Document Type	10-K
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		151,606,607
Entity Public Float			$ 1,211,011
Amendment Flag	false
Entity Central Index Key	0001419793
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	Dec. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	333-147980
Entity Incorporation, State or Country Code	NV
Entity Interactive Data Current	Yes

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
CURRENT ASSETS
Cash	$ 409,591	$ 490,614
Restricted cash - Preferred shares	6,530
Contracts receivable	438,430	522,911
Contract assets	148,734	26,287
Convertible note receivable		117,879
Other receivable	3,799	2,500
Prepaid expenses	52,728	47,483
TOTAL CURRENT ASSETS	1,059,812	1,207,674
NET PROPERTY AND EQUIPMENT	258,206	117,069
OTHER ASSETS
Fair value investment-securities	8,000	9,600
Trademark	4,467	4,467
Security deposit		3,500
TOTAL OTHER ASSETS	12,467	17,567
TOTAL ASSETS	1,330,485	1,342,310
Current Liabilities
Accounts payable and other payable	1,304,803	1,144,545
Accrued expenses	1,542,816	1,163,146
Cumulative preferred stock dividends payable	256,274	92,472
Contract liabilities	340,551	428,009
Capital lease, current portion	9,088	9,088
Customer deposit	146,453	136,765
Warranty reserve	20,000	20,000
Loan payable, merchant cash advance, net of finance fees of $0 and $12,566 respectively	342,896	427,214
Loan payable, related party	94,883	187,054
Loans payable, SBA	505,000
Derivative liabilities	12,310,307	31,640,470
Capital lease, long term portion	7,985
COMMITMENTS AND CONTINGENCIES (See Note 12)
Total	6,331,409	2,204,025
SHAREHOLDERS’ DEFICIT
Subscription payable to purchase	100,000
Preferred treasury stock,1,000 and 1,000 shares outstanding, respectively
Common stock, $0.0001 par value, 16,000,000,000 shares authorized 65,052,688 and 4,854,993 equity shares issued and outstanding, respectively	6,505	486
Additional paid in capital	64,265,217	62,711,339
Accumulated other comprehensive loss	(132)	(134)
Accumulated deficit	(94,020,294)	(107,281,659)
TOTAL SHAREHOLDERS’ DEFICIT	(29,645,300)	(44,565,901)
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT	1,330,485	1,342,310
Series F 8% Preferred Stock
Current Liabilities
Preferred stock value	175,000	1,678,000
Series F 8% Preferred Stock One
Current Liabilities
Preferred stock value	100,000
Series G 8% Preferred Stock
Current Liabilities
Preferred stock value	430,000	530,000
Series I 8% Preferred Stock
Current Liabilities
Preferred stock value	797,400	797,400
Series K 8% Preferred Stock
Current Liabilities
Preferred stock value	3,160,417	2,000,650
Convertible promissory notes, net of discount of $17,930 and $146,005, respectively	1,223,228	2,879,325
Total Current Liabilities	22,759,116	43,134,138
Capital lease, long term portion	7,985	17,073
Convertible promissory notes, net of discount of $0 and $0, respectively	1,877,275	552,975
Total Long Term Liabilities	1,885,260	570,048
Total Liabilities	24,644,376	43,704,186
Series J Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	272,500	348,700
Series L Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	1,132,084	1,000,325
Series M Preferred Stock
Current Liabilities
Convertible Preferred Stock	1,060,325	855,000
Series O 8% Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	1,995,000
Series P Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	356,500
Series Q 12% Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	1,025,000
Series R 10% Convertible Preferred Stock
Current Liabilities
Convertible Preferred Stock	490,000
Series C Preferred Stock
Current Liabilities
Preferred stock value
Series D-1 Preferred Stock
Current Liabilities
Preferred stock value	3,250	3,850
Series E Preferred Stock
Current Liabilities
Preferred stock value	$ 154	$ 217

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Merchant cash advances, net of finance fees (in Dollars)	$ 0	$ 12,566
Preferred treasury stock, shares outstanding	1,000	1,000
Common stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized	16,000,000,000	16,000,000,000
Common stock, shares issued	65,052,688	4,854,993
Common stock, shares outstanding	65,052,688	4,854,993
Series F 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 175,000	$ 1,678,000
Preferred stock, share issued	175	1,678
Preferred stock, share outstanding	175	1,678
Series F 8% Preferred Stock One
Preferred stock, redeemable value (in Dollars)	$ 100,000	$ 0
Preferred stock, share issued	100	0
Preferred stock, share outstanding	100	0
Series G 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 430,000	$ 530,000
Preferred stock, share issued	430	530
Preferred stock, share outstanding	430	530
Series I 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 797,400	$ 797,400
Preferred stock, share issued	797	797
Preferred stock, share outstanding	797	797
Series K 8% Preferred Stock
Preferred stock, redeemable value (in Dollars)	$ 3,160,417	$ 2,000,650
Preferred stock, share issued	3,160	2,001
Preferred stock, share outstanding	3,160	2,001
Net of discount current (in Dollars)	$ 17,930	$ 146,005
Net of discount non current (in Dollars)	0	0
Series J Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 272,500	$ 348,700
Convertible preferred stock, share issued	273	349
Convertible preferred stock, share outstanding	273	349
Series L Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,132,084	$ 1,000,325
Convertible preferred stock, share issued	1,132	1,000
Convertible preferred stock, share outstanding	1,132	1,000
Series M Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,060,325	$ 855,000
Convertible preferred stock, share issued	42,213	34,200
Convertible preferred stock, share outstanding	42,213	34,200
Series O 8% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,995,000	$ 0
Convertible preferred stock, share issued	1,995	1,995
Convertible preferred stock, share outstanding	1,995	1,995
Series P Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 356,500	$ 0
Convertible preferred stock, share issued	357	0
Convertible preferred stock, share outstanding	357	0
Series Q 12% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 1,025,000	$ 0
Convertible preferred stock, share issued	1,025	0
Convertible preferred stock, share outstanding	1,025	0
Series R 10% Convertible Preferred Stock
Convertible preferred stock, redeemable value (in Dollars)	$ 490,000	$ 0
Convertible preferred stock, share issued	490	0
Convertible preferred stock, share outstanding	490	0
Series C Preferred Stock
Preferred stock, share issued	1,000	1,000
Preferred stock, share outstanding	1,000	1,000
Preferred stock, par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	550,000,000	550,000,000
Series D-1 Preferred Stock
Preferred stock, share issued	32,500,000	38,500,000
Preferred stock, share outstanding	32,500,000	38,500,000
Series E Preferred Stock
Preferred stock, share issued	1,537,213	2,139,649
Preferred stock, share outstanding	1,537,213	2,139,649

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Sales	$ 4,101,131	$ 3,587,894
Cost of Goods Sold	3,489,356	3,217,028
Gross Profit	611,775	370,866
Operating Expenses
Selling and marketing expenses	1,557,842	1,572,183
General and administrative expenses	3,602,586	2,556,201
Research and development	110,338	107,351
Depreciation expense	52,247	43,369
Total Operating Expenses	5,323,013	4,279,104
Loss from Operations	(4,711,238)	(3,908,238)
OTHER INCOME (EXPENSE)
Other income	16,521	32,980
Impairment expense	(133,879)
Unrealized gain(loss) on investment securities	(1,600)	(13,200)
Gain (Loss) on settlement of payable		28,428
Amortization of finance fees and cost		(147,924)
Loss on settlement of convertible notes		(348,307)
Loss on conversion of debt		(102,527)
Gain (Loss) on net change in derivative liability and conversion of debt	19,359,866	(22,280,266)
Interest expense	(1,268,305)	(734,624)
TOTAL OTHER INCOME (EXPENSE)	17,972,603	(23,565,440)
NET INCOME (LOSS)	$ 13,261,365	$ (27,473,678)
BASIC EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0.64	$ (12.66)
DILUTED EARNINGS (LOSS) PER SHARE ATTRIBUTABLE TO SHAREHOLDERS’ (in Dollars per share)	$ 0.04	$ (12.66)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, BASIC (in Shares)	20,651,668	2,170,270
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING, DILUTED (in Shares)	312,352,351	2,170,270

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Deficit - USD ($)	Preferred stock	Common stock	Additional Paid-in- Capital	Subscription Payable	Accumulated Other Comprehensive loss	Accumulated Deficit	Mezzanine Equity	Total
Balance at Dec. 31, 2018	$ 4,064	$ 88	$ 63,179,433		$ (134)	$ (79,807,981)		$ (16,624,530)
Balance (in Shares) at Dec. 31, 2018	40,640,649	875,244
Reclassification of equity to mezzanine			(2,204,025)				$ 2,204,025	(2,204,025)
Reclassification of equity to mezzanine (in Shares)
Common stock issuance for conversion of debt and accrued interest		$ 265	729,001					729,266
Common stock issuance for conversion of debt and accrued interest (in Shares)		2,647,017
Common stock issued at fair value for services		$ 107	706,155					706,262
Common stock issued at fair value for services (in Shares)		1,070,855
Common stock issued through a private placement for purchase of Series G Preferred stock		$ 8	(8)
Common stock issued through a private placement for purchase of Series G Preferred stock (in Shares)		82,799
Series J preferred stock converted into common stock		$ 17	(17)
Series J preferred stock converted into common stock (in Shares)		171,176
Issuance of Series M Preferred stock in exchange for convertible note	3		171,257					171,260
Issuance of Series M Preferred stock in exchange for convertible note (in Shares)
Cumulative preferred stock dividend			27,017					27,017
Loss on conversion of debt			102,527					102,527
Net Income (loss)						(27,473,678)		(27,473,678)
Balance at Dec. 31, 2019	$ 4,067	$ 486	62,711,339		(134)	(107,281,659)	2,204,025	(44,565,901)
Balance (in Shares) at Dec. 31, 2019	40,640,649	4,854,993
Rounding	$ (3)	$ (1)	(1)					(5)
Common stock issuance for conversion of debt and accrued interest		$ 1,928	390,922					392,850
Common stock issuance for conversion of debt and accrued interest (in Shares)		19,276,917
Common stock issued at fair value for services		$ 774	414,262					415,036
Common stock issued at fair value for services (in Shares)		7,750,037
Common stock issued for conversion of Series D-1 Preferred stock	$ (600)	$ 30	24,348					23,778
Common stock issued for conversion of Series D-1 Preferred stock (in Shares)	(6,000,000)	295,141
Common stock issued for conversion of Series E Preferred stock	$ (60)	$ 3	57
Common stock issued for conversion of Series E Preferred stock (in Shares)	(602,436)	30,124
Common stock issued for conversion of Series J Preferred stock		$ 231	75,969				(76,200)	76,200
Common stock issued for conversion of Series J Preferred stock (in Shares)		2,313,689
Common stock issued for conversion of Series L Preferred stock		$ 1,849	446,276				(448,125)	448,125
Common stock issued for conversion of Series L Preferred stock (in Shares)		18,486,913
Common stock issued for conversion of Series M Preferred stock		$ 14	7,986				(8,000)	8,000
Common stock issued for conversion of Series M Preferred stock (in Shares)		137,052
Common stock issued for Series O Preferred stock dividends		$ 69	(69)				1,670,000
Common stock issued for Series O Preferred stock dividends (in Shares)		688,205
Common stock issued for conversion of Series P Preferred stock		$ 808	141,442				(142,250)	142,250
Common stock issued for conversion of Series P Preferred stock (in Shares)		8,079,477
Common stock issued for conversion of Series Q Preferred stock		$ 314	52,686				(53,000)	53,000
Common stock issued for conversion of Series Q Preferred stock (in Shares)		3,140,140
Issuance of Series M Preferred stock through a private placement							213,300
Issuance of Series K preferred stock with issuance of Series L through a private placement							580,000
Issuance of Series P preferred stock with issuance of Series O through a private placement							417,500
Issuance of Series P preferred stock with issuance of Series O through a private placement (in Shares)
Issuance of Series R preferred stock through a private placement							490,000
Issuance of Series R preferred stock through a private placement (in Shares)
Exchange of Series Preferred Stock for Series O/P Preferred stock							1,278,000
Exchange of Series Preferred Stock for Series O/P Preferred stock (in Shares)
Exchange of Series F Preferred Stock for Series O/P Preferred stock							206,159
Exchange of Series F Preferred Stock for Series O/P Preferred stock (in Shares)
Subscription payable - common stock				100,000				100,000
Subscription payable - common stock (in Shares)		32,482,536
Comprehensive gain					2			2
Common stock reverse split share adjustment		$ 1	(1)
Common stock reverse split share adjustment (in Shares)		7,902
Net Income (loss)						13,261,365		13,261,365
Balance at Dec. 31, 2020	$ 3,404	$ 6,505	$ 64,265,217	$ 100,000	$ (132)	$ (94,020,294)	$ 6,331,409	$ (29,645,300)
Balance (in Shares) at Dec. 31, 2020	34,038,213	65,052,688

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Statement of Cash Flows [Abstract]
Net Income (loss)	$ 13,261,365	$ (27,473,678)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation	52,247	43,369
Interest expense associated with preferred stock issuance	1,078,659
Preferred stock issued for services	23,778
Common stock issued for services	415,036	706,262
(Gain) Loss on net change in valuation of derivative liability	(19,359,866)	22,280,266
Loss on conversion of preferred stock		102,527
Loss on settlement of debt		348,307
Debt discount amortization	11,774	146,005
Accrued interest on note receivable		(32,979)
Net unrealized (gain)loss on fair value of security	1,600	13,200
Interest receivable on convertible note receivable	(16,000)
Impairment expense for convertible note receivable	133,879
Amortization of financing fees and cost		165,552
Gain on settlement of payable		(28,428)
Change in Assets (Increase) Decrease in:
Contracts receivable	84,481	(213,688)
Contract asset	(122,447)	84,714
Prepaid expenses and other assets	(1,745)	12,837
Other receivable	(1,299)	(2,500)
Change in Liabilities Increase (Decrease) in:
Accounts payable	82,758	167,821
Accrued expenses	457,352	127,928
Contract liabilities	(87,458)	315,115
Customer deposit	9,688	16,077
NET CASH USED IN OPERATING ACTIVITIES	(3,976,198)	(3,221,293)
CASH FLOWS USED FROM INVESTING ACTIVITIES:
Purchase of fixed assets	(13,884)	(6,188)
CASH USED IN INVESTING ACTIVITIES	(13,884)	(6,188)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payments on capital lease	(9,088)	(9,845)
Loan payable financing, net	(84,318)	(184,625)
Loan payable, related party, net	(92,170)
Loan payable, PPP	505,000
Net cumulative preferred stock dividends payable	163,802	40,371
Payment on redemption of preferred stock		(65,000)
Net proceeds for issuance of convertible notes	(704)
Net proceeds for issuance of preferred stock for cash - equity	2,373,300
Net proceeds for issuance of preferred stock for cash - liability	1,059,767	3,328,050
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,915,589	3,108,951
NET (DECREASE) INCREASE IN CASH	(74,493)	(118,530)
CASH BEGINNING OF YEAR	490,614	609,144
CASH END OF YEAR	416,121	490,614
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	23,186	59,528
Taxes paid
SUPPLEMENTAL DISCLOSURES OF NON CASH TRANSACTIONS
Common stock issued at fair value for conversion of debt, plus accrued interest, and other fees	392,850	729,266
Other payable for fixed asset with common stock subscription	179,500
Issuance of Series O dividends	69
Issuance of Series M for debt settlement		171,260
Preferred stock converted to common stock	727,635	17
Stock issued through private placement		$ 8

Organization and Line of Busine

Organization and Line of Business	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. ORGANIZATION AND LINE OF BUSINESS Organization OriginClear, Inc. (the “Company”) was incorporated in the state of Nevada on June 1, 2007. The Company, based in Los Angeles, California, began operations on June 1, 2007. The Company began its planned principal operations in December, 2010, at which time it exited the development stage. In December 2014, the Company formed a wholly owned subsidiary, OriginClear Technologies Limited (OCT), formerly OriginClear (HK) Limited in Hong Kong, China. The Company granted OCT a master license for the People’s Republic of China. In turn, OCT is expected to license regional joint ventures for water treatment. As of December 31, 2020, OCT has limited assets and operations. On October 1, 2015, the Company completed the acquisition of 100% of the total issued and outstanding stock of Progressive Water Treatment, Inc. (“PWT”) and is included in these consolidated financial statements as a wholly owned subsidiary. On July 19, 2018, the Company announced the launch of its Modular Water Treatment Division. MWS designs, manufactures and implements advanced prepackaged wastewater treatment, pump stations and custom systems with primary focus on decentralized opportunities away from the very competitive large municipal wastewater treatment plants. These decentralized opportunities include: rural communities, housing developments, industrial sites, schools and many more. On April 13, 2021, OriginClear announced that it had created a wholly-owned subsidiary called Water On Demand #1, Inc. (WOD #1), to offer private businesses the ability to pay for their water treatment and purification services on a pay-per-gallon basis. The Company is in the process of selecting a use case for delivering such services, commonly-known as Design-Build-Own-Operate or DBOO. The program cannot move forward without capital invested into WOD #1. On May 10, 2021, OriginClear announced that it had recently filed “System And Method For Water Treatment Incentive”, a patent application for using blockchain technology and non-fungible tokens (NFT) to simplify the distribution of payments on outsourced water treatment and purification services billed on a pay-per-gallon basis ahead of inflation. The Company is currently developing this blockchain technology and NFT under the name $H2O, and applied for a trademark for this name on May 16, 2021. The Company is aware of a high level of regulatory oversight in this area, and if implementation of $H20 is delayed or terminated altogether by reason of regulatory issues, it will employ traditional payment systems. Line of Business OriginClear is a provider of water treatment solutions and master licensee of a breakthrough water equipment technology. This technology enables the Company to offer prefabricated, modular water systems, which are suited for local businesses. The Company also plans to deploy this technology for outsourced water treatment programs in which the customer pays by the gallon, without capital expenditure. Blockchain technology may be employed to streamline payments. Through the acquisition of Progressive Water Treatment Inc., the Company is primarily engaged in providing water treatment systems and services for a wide variety of applications and component sales. Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. These factors, among others raise substantial doubt about the Company’s ability to continue as a going concern. Our independent auditors, in their report on our audited financial statements for the year ended December 31, 2020 expressed substantial doubt about our ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, achieving a level of profitable operations and receiving additional cash infusions. During the year ended December 31, 2020, the Company obtained funds from the issuance of convertible note agreements and from sales of its preferred stock. Management believes this funding will continue from its’ current investors and from new investors. The Company also generated revenue of $4,101,131 and has standing purchase orders and open invoices with customers which will provide funds for operations. Management believes the existing shareholders, the prospective new investors and future sales will provide the additional cash needed to meet the Company’s obligations as they become due and will allow the development of its core business operations. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain restrictions on our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case of equity financing. Reverse Stock Split On October 25, 2019, the Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the “Reverse Split”). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split.

Summary of Significant Accounti

Summary of Significant Accounting Polices	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2020, the cash balance in excess of the FDIC limits was $159,591. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Net Earnings (Loss) per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2020 and 2019, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Years Ended 2020 2019 Income (Loss) to common shareholders (Numerator) $ 13,261,365 $ (27,473,678 ) Basic weighted average number of common shares outstanding (Denominator) 20,651,668 2,170,270 Diluted weighted average number of common shares outstanding (Denominator) 312,352,351 2,170,270 Year ended December 31, 2020 The Company has included 15,800,000 warrants to purchase common shares, shares issuable from convertible debt of $3,100,503 and shares issuable from convertible preferred stock for the year ended December 31, 2020, because their impact on the earnings per share is dilutive. Year ended December 31, 2019 The Company has excluded 122,044 warrants, shares issuable from convertible debt of $3,432,300 and shares issuable from convertible preferred stock for the year ended December 31, 2019, because their impact on the loss per share is anti-dilutive. Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs. Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 and $0 as of December 31, 2020 and 2019, respectively. The net contract receivable balance was $438,430 and $522,911 at December 31, 2020 and 2019, respectively. Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at December 31, 2020 and 2019, and determined there was no impairment of indefinite lived intangibles and goodwill. Research and Development Research and development costs are expensed as incurred. Total research and development costs were $110,338 and $107,351 for the years ended December 31, 2020 and 2019, respectively. Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $211,296 and $48,594 for the years ended December 31, 2020 and 2019, respectively. Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years December 31, 2020 2019 Machinery and Equipment $ 383,569 $ 193,570 Computer Equipment 62,854 59,468 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 409,988 Less accumulated depreciation (345,167 ) (292,919 ) Net Property and Equipment $ 258,206 $ 117,069 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the year ended December 31, 2020 and 2019, was $52,247 and $43,369, respectively. Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date. Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2020, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2020 and 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2020 $ 8,000 $ 8,000 $ - $ - Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2020 $ 12,310,307 $ - $ - $ 12,310,307 Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Loss on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 31,640,470 Fair Value of derivative liabilities issued 29,703 Loss on conversion of debt and change in derivative liability (19,359,866 ) Balance as of December 31, 2020 $ 12,310,307 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 12/31/2020 12/31/2019 Risk free interest rate 0.08% - 0.13 % 1.48% - 1.69% Stock volatility factor 127.0% - 249.0 % 116.0% - 338.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated. Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income. Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered. Reclassification Certain prior period accounts and balances have been reclassified to current period presentation for comparative purposes. Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company’s audited consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s audited consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s audited consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2020
Stockholders' Equity Note [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock Series C On March 14, 2017, the Board of Directors authorized the issuance of 1,000 shares of Series C preferred stock, par value $0.0001 per share, to T. Riggs Eckelberry in exchange for his continued employment with the Company. The holder of Series C preferred stock is not entitled to receive dividends, is not entitled to any liquidation preference and shares of Series C preferred stock does not have any conversion rights. The Series C Preferred Stock entitles the holder to 51% of the total voting power of our stockholders. The purchase price of the Series C preferred stock was $0.0001 per share representing a total purchase price of $0.10 for 1,000 shares. As of December 31, 2020, there were 1,000 shares of Series C preferred stock outstanding held by Mr. Eckelberry. Series D-1 On April 13, 2018, the Company designated 50,000,000 shares of its authorized preferred stock as Series D-1 preferred stock. The shares of Series D-1 preferred stock are not entitled to dividends and do not have a liquidation preference. Each share of Series D-1 preferred stock is convertible into 0.0005 of one share of common stock. The Series D-1 preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock, which amount may be increased to 9.99% at the holders discretion upon 61 days’ written notice. During the year ended December 31, 2020, the Company issued 295,141 shares of common stock upon conversion of 6,000,000 shares of Series D-1 preferred stock with a value of $23,778 using the closing stock price on grant date. The Company did not recognize any gain or loss on conversion, as the shares were converted within the terms of the agreement. Series E On August 14, 2018, the Company designated 4,000,000 shares of its authorized preferred stock as Series E preferred stock. The shares of Series E preferred stock are not entitled to dividends and not have a liquidation preference. Each share of Series E preferred stock is convertible into 0.05 shares of common stock. The shares of Series E preferred stock do not carry any voting rights. The Series E preferred stock may not be converted to common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of our outstanding common stock which amount may be increased to 9.99% at the holders discretion. During the year ended December 31, 2020, the Company issued 30,124 shares of common stock upon conversion of 602,436 shares of Series E preferred stock. The Company did not recognize any gain or loss on conversion, as the shares were converted within the terms of the agreement. Series F On August 14, 2018, the Company designated 6,000 shares as Series F preferred stock. The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020. During the year ended December 31, 2020, the Company exchanged 1,278 shares of Series F preferred stock for 1,278 shares of Series Q preferred stock. As of December 31, 2020, there were 275 shares of Series F preferred stock issued and outstanding. As of December 31, 2020, a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022, and the Company agreed to pay such holder, in addition to any dividends payable on such holder’s Series F preferred stock, an annual fee of 4% of the stated value of such holder’s shares of Series F preferred stock. Excluding such 100 shares, as of December 31, 2020, the Company had 175 outstanding shares of Series F preferred stock which the Company was required to, and failed to redeem on September 1, 2020, and was in default for an aggregate redemption price (equal to the stated value) of $175,000. Series G On January 16, 2019, the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000, which is recognized as a long-term liability. As of December 31, 2019, the Company issued an aggregate of 82,799 shares of its common stock to certain holders of its Series G preferred stock. During the year ended December 31, 2020 Series I On April 3, 2019, the Company designated 4,000 shares of preferred stock as Series I. The Series I has a stated value of $1,000 per share. Series I holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series I are not entitled to any voting rights except as may be required by applicable law, and are not convertible into common stock. The Company will have the right to redeem the Series I at any time while the Series I are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series I two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series I between May 2, 2021 and June 10, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the year ended December 31, 2019, the Company issued an aggregate of 797 shares of its Series I preferred stock for an aggregate purchase price of $797,400. As of December 31, 2020, there were 797 shares of Series I preferred stock issued and outstanding. Series J On April 3, 2019, the Company designated 100,000 shares of preferred stock as Series J. The Series J has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series J preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series J COD, which includes certain Make-Good Shares for certain prior investors. During the year ended December 31, 2020 and 2019 Series K On June 3, 2019, the Company designated 4,000 shares of preferred stock as Series K. The Series K has a stated value of $1,000 per share. Series K holders are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly within 60 days from the end of each fiscal quarter. The Series K is not be entitled to any voting rights except as may be required by applicable law, and is not convertible into common stock. The Company will have the right to redeem the Series K at any time while the Series K are outstanding at a price equal to the stated value plus any accrued but unpaid dividends. The Company will be required to redeem the Series K two years following the date that is the later of the (i) final closing of the tranche (as designated in the applicable subscription agreement) or (ii) the expiration date of the tranche that such shares to be redeemed were a part of. The Company is required to redeem such shares of Series K between August 5, 2021 and April 24, 2022, at a price equal to the stated value plus any accrued but unpaid dividends. The issuance of the shares were accounted for under ASC 480-10-25-4, which requires liability treatment for certain mandatorily redeemable financial instruments, and the cumulative dividends are recorded as interest expense. During the year ended December 31 Series L On June 3, 2019, the Company designated 100,000 shares of preferred stock as Series L. The Series L has a stated value of $1,000 per share and holders are entitled to receive dividends on an as-converted basis with the Company’s common stock. The Series L preferred stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Series L COD, which includes certain Make-Good Shares for certain prior investors. During the year ended December 31 Series M Pursuant to the Amended and Restated Certificate of Designation of Series M Preferred Stock filed with the Secretary of State of Nevada on July 1, 2020, the Company designated 800,000 shares of its preferred stock as Series M Preferred Stock. Each share of Series M Preferred Stock has a stated value of $25. The Series M Preferred Stock is not convertible into common stock. The holders of outstanding shares of Series M Preferred Stock are entitled to receive dividends, at the annual rate of 10%, payable monthly, payable in preference and priority to any payment of any dividend on the common stock. The Series M Preferred Stock is entitled to a liquidation preference in an amount equal to $25 per share plus any declared but unpaid dividends, before any payments to holders of common stock. The Series M Preferred Stock have no pre-emptive or subscription rights, and there are no sinking fund provisions applicable to the Series M Preferred Stock. The Series M Preferred Stock does not have voting rights, except as required by law and with respect to certain protective provisions set forth in the Certificate of Designation of Series M Preferred Stock. To the extent it may lawfully do so, the Company may, in its sole discretion, at any time when there are outstanding shares of Series M Preferred Stock, redeem any or all of the then outstanding shares of Series M Preferred Stock at a redemption price of $37.50 per share (150% of the stated value) plus any accrued but unpaid dividends. During the year ended December 31 year ended December 31 Pursuant to an exchange agreement, on December 11, 2019, the Company issued 34,200 shares of Series M Preferred Stock of the Company to a note holder in exchange for an outstanding convertible note of the Company in the amount of $171,260 (including accrued interest thereon). No gain or loss was recognized on the exchange of the note. Series O On April 27, 2020, the Company designated 2,000 shares of preferred stock as Series O Preferred Stock. The Series O Preferred Stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends (i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O Preferred Stock. The Series O Preferred Stock does not have voting rights except as required by law. The Series O Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O Preferred Stock being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company has the right (but no obligation) to redeem the Series O Preferred Stock at any time while the Series O Preferred Stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the year ended December 31, 2020, the Company issued an aggregate of 1,995 shares of Series O Preferred Stock for an aggregate purchase price of $1,775,000, plus a rollover from Series F in the amount of $125,000 and a rollover from Series Q in the amount of $200,000. As of December 31, 2020, there were 1,995 shares of Series O preferred stock issued and outstanding, the Company issued an aggregate of 688,205 shares of common stock in prorated 4% annualized dividends. Series P On April 27, 2020, the Company designated 500 shares of preferred stock as Series P Preferred Stock. The Series P Preferred Stock has a stated value of $1,000 per share, and entitles holders to receive dividends on an as-converted basis with the Company’s common stock. The Series P Preferred Stock is convertible into shares of the Company’s common stock, on the terms and conditions set forth in the Certificate of Designation of Series P Preferred Stock, which includes certain make-good shares for certain prior investors, and provided that, the Series P Preferred Stock may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Series P Preferred Stock entitles the holders to a payment on an as-converted and pari passu basis with the common stock upon any liquidation. The Series P Preferred Stock has no preemptive or subscription rights, and there is no sinking fund or redemption provisions applicable to the Series P Preferred Stock. The Series P Preferred Stock votes on an as-converted basis with the common stock, subject to the beneficial ownership limitation. During the year ended December 31, 2020, the Company issued an aggregate of 417 shares of Series P Preferred Stock for proceeds of $417,500. Also, the Company received a rollover from Series F of 31 preferred stock and a rollover from Series Q of 50 shares of preferred stock for an increase of 81 shares of Series P Preferred Stock. During the year ended December 31, 2020, the Company issued 8,079,477 shares of common stock for conversion of 143 shares of Series P Preferred stock. As of December 31, 2020, there were 357 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q Preferred Stock. The Series Q Preferred Stock does not have voting rights except as required by law. The Series Q Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q Preferred Stock being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series Q Preferred Stock at any time while the Series Q Preferred Stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the year ended December 31, 2020, the Company issued an aggregate of 1,278 shares of Series Q Preferred Stock in exchange for 1,278 shares of Series F Preferred Stock. During the year ended December 31, 2020, 53 shares of Series Q preferred stock were converted into 3,140,140 shares of common stock. Also, there was a rollover from Series F preferred stock of 90 shares, plus a rollover from Series Q to Series O preferred stock for 200 shares. For the year ended December 31, 2020, the Company recognized a gain on conversion of Series Q preferred stock in the amount of $5,226. As of December 31, 2020, there were 1,025 shares of Series Q preferred stock issued and outstanding. Series R On November 16, 2020, the Company designated 5,000 shares of preferred stock as Series R Preferred Stock. The Series R has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series R Preferred Stock holders are not entitled to any voting rights except as may be required by applicable law. The Series R Preferred Stock are convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series R being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series R may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series R at any time while the Series R are outstanding at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid cash dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. The subscribers were offered warrants with the purchase of Series R. During the year ended December 31 As of December 31, 2020, the Company accrued aggregate dividends in the amount of $256,274 for all series of preferred stock. The Series J, Series L, Series M, Series O, Series P, Series Q and Series R preferred stock are accounted for outside of permanent equity due to the terms of conversion at a market component or stated value of the preferred stock. Common Stock On April 23, 2019, the Company filed a certificate of amendment to its articles of incorporation, with the Secretary of the State of Nevada effectuate an increase to the number of authorized shares of common stock of the Company from 8,000,000,000 shares from 16,000,000,000. Year ended December 31, 2020 The Company issued 19,276,917 shares of common stock for the settlement of convertible promissory notes in an aggregate principal amount of $137,262, plus interest in the amount of $51,186, and a default settlement of $204,402, based upon conversion prices of $0.00955 to $0.0394. The Company issued 7,750,037 shares of common stock for services at fair value of $415,036. The Company issued 688,205 shares of common stock for preferred stock dividends payable. The Company issued 32,482,536 shares of common stock upon conversion of 6,603,479 shares of preferred stock. Year ended December 31, 2019 The Company issued 2,647,017 shares of common stock for the settlement of convertible promissory notes in an aggregate principal in the amount of $535,035, plus interest in the amount of $116,306, and a default settlement of $77,925, with an aggregate fair value loss on conversion of debt in the amount of $102,527, based upon conversion prices of $0.05 to $1.84. The Company issued 1,070,855 shares of common stock for services at fair value of $706,262. The Company issued 82,799 shares of common stock in a private placement as additional consideration for the purchase of Series G preferred stock. The Company issued 171,176 shares of common stock upon conversion of 50 shares of Series J preferred stock.

Options and Warrants

Options and Warrants	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
OPTIONS AND WARRANTS	4. OPTIONS AND WARRANTS Restricted Stock to CEO Between May 12, 2016, and August 14, 2019, the Company entered into Restricted Stock Grant Agreements (“the RSGAs”) with its Chief Executive Officer, Riggs Eckelberry, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the RSGAs are performance based shares and none have yet vested nor have any been issued. The RSGAs provides for the issuance of up to an aggregate of 109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 54,607 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization Restricted Stock to Employees and Consultants Between May 12, 2016, and August 14, 2019, the Company entered into Restricted Stock Grant Agreements (“the E&C RSGAs”) with its employees and consultants, to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the E&C RSGAs are performance based shares and none have yet vested nor have any been issued. The E&C RSGAs provide for the issuance of up to 378,750 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 189,375 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), On August 14, 2019, the Board of Directors approved an amendment to the RSGAs and E&C RSGAs to include an alternative vesting schedule for the Grantees. The Grantees can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company’s common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs and E&C RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs and E&C RSGAs. The fair market value shall equal the average of the trailing ten (10) closing trade prices of the Company’s common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company’s common stock is then traded. If the fair market value of the Company’s common stock on the date the shares are vested is less than the fair market value of the Company’s common stock on the effective date of the RSGA or E&C RSGA, then the number of vested shares issuable (assuming all conditions are satisfied) shall be increased so that the aggregate fair market value of vested shares issuable on the vesting date equals the aggregate fair market value that such number of shares would have had on the effective date. Upon the occurrence of a Company performance goal, the right to participate in the alternate vesting schedule will terminate, and the vesting of the remaining unvested shares will be as set forth under the restricted stock award agreement. On May 18, 2020, the Company entered into Restricted Stock Grant Agreements (the “May RSGAs”) with its Chief Executive Officer, T. Riggs Eckelberry, members of the Board, employees and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGAs are performance-based shares and none have yet vested nor have any been issued. The May RSGAs provide for the issuance of up to an aggregate of 10,500,000 shares of the Company’s common stock as follows: 2,000,000 to Mr. Eckelberry, 500,000 to each of the other three members of the Board, and an aggregate of 7,000,000 to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 5,250,000 shares of its common stock; b) If the Company’s consolidated operating profit ( Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), During the year ended December 31, 2020, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs Eckelberry, one employee and one consultant an aggregate of 1,181,123 shares of the Company’s common stock with a value of $40,019, calculated using the closing share prices on the dates of the vesting agreements. Warrants During the year ended December 31, 2020, the Company issued 15,800,000 purchase warrants, associated with the Series R preferred stocks. A summary of the Company’s warrant activity and related information follows for the years ended December 31, 2020 and 2019: 2020 2019 Weighted Weighted Number average Number average of exercise of exercise Warrants price Warrants price Outstanding - beginning of year $ 122,044 $ 500.00 $ 125,456 $ 740 Granted 15,800,000 $ 0.03 - $ - Exercised $ - $ - Forfeited $ (3,412 ) $ 240 Outstanding - end of year 15,922,044 $ 500.03 $ 122,044 $ 500 At December 31, 2020 and 2019, the weighted average remaining contractual life of warrants outstanding: 2020 2019 Weighted Weighted Remaining Remaining Exercisable Warrants Warrants Contractual Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) Outstanding Exercisable Life (years) $ 0.05 9,800,000 - - - $ 0.10 6,000,000 $ 500.00 122,044 122,044 1.37 122,044 122,044 1.62 15,922,044 122,044 122,044 At December 31, 2020, the aggregate intrinsic value of the warrants outstanding was $0.

Convertible Promissory Notes

Convertible Promissory Notes	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of December 31, 2020, the outstanding convertible promissory notes are summarized as follows: Convertible Promissory Notes $ 3,100,503 Less current portion 1,223,228 Total long-term liabilities $ 1,877,275 Maturities of long-term debt for the next four years are as follows: Year Ending December 31, Amount 2021 1,241,158 2022 1,815,000 2023 62,275 $ 3,118,433 At December 31, 2020, the $3,118,433 in convertible promissory notes and has a remaining debt discount $17,930, leaving a net balance of $3,100,503. On various dates from 2014 through May 2015, the Company issued unsecured convertible promissory notes (the “2014-2015 Notes”), that matured on various dates and were extended sixty (60) months from the effective date of each Note. The 2014-2015 Notes bear interest at 10% per year. The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes. In addition, for as long as the 2014-2015 Notes or other convertible notes in effect between the purchaser and the Company are outstanding, if the Company issues any security with terms more favorable than the terms of the 2014-2015 Notes or such other convertible notes or a term was not similarly provided to the purchaser of the 2014-2015 Notes or such other convertible notes, then such more favorable or additional term shall, at the purchaser’s option, become part of the 2014-2015 Notes and such other convertible notes. The conversion feature of the 2014-2015 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2014-2015 Notes. During the year ended December 31, 2020, the Company issued 6,709,160 shares of common stock, upon conversion of $89,400 in principal, plus accrued interest of $51,186. As of December 31, 2020, the 2014-2015 Notes had an aggregate remaining balance of $1,011,150, of which $615,000 is long term. The unsecured convertible promissory notes (the “OID Notes”) had an aggregate remaining balance of $184,124, plus accrued interest of $13,334. The OID Notes included an original issue discount and one-time interest, which has been fully amortized. The OID Notes matured on December 31, 2017, which were extended to June 30, 2018. The OID Notes were convertible into shares of the Company’s common stock at a conversion price initially of $30,620. After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date. The conversion feature of the notes was considered a derivative in accordance with current accounting guidelines, because of the reset conversion features of the notes. During the year ended December 31, 2020, the Company issued 130,711 shares of common stock upon conversion of principal in the amount of $5,150. As of December 31, 2020, the remaining balance was $62,275, which is long term. The Company issued various, unsecured convertible promissory notes (the “2015-2016 Notes”), on various dates ending on May 19, 2016. The 2015-2016 Notes matured and were extended from the date of each tranche through maturity dates ending on May 19, 2020. The 2015-2016 Notes bear interest at 10% per year. The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes. The conversion feature of the 2015-2016 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the 2015-2016 Notes. As of December 31, 2020, the remaining balance of the 2015-2016 Notes was $1,200,000, which is long term. The Company issued a convertible note (the “Dec 2015 Note”) in exchange for accounts payable in the amount of $432,048, which could be converted into shares of the Company’s common stock after December 31, 2015. The Dec 2015 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Dec 2015 Note did not meet the criteria of a derivative, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Dec 2015 Note and recognized as interest expense in the financial statements. On January 1, 2016, the Dec 2015 Note met the criteria of a derivative and was accounted for under ASC 815. The Dec 2015 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. As of December 31, 2020, the remaining balance on the Dec 2015 Note was $167,048, which is short term. The Company issued a convertible note (the “Sep 2016 Note”) in exchange for accounts payable in the amount of $430,896, which could be converted into shares of the Company’s common stock after September 15, 2016. The Sep 2016 Note was accounted for under ASC 470, whereby, a beneficial conversion feature was recorded at time of issuance. The Sep 2016 Note met the criteria of a derivative and was accounted for under ASC 815. The Sep 2016 Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion. The Sep 2016 Note did not meet the criteria of a derivative at the date of the issuance, and was accounted for as a beneficial conversion feature, which was amortized over the life of the Sep 2016 Note and recognized as interest expense in the financial statements. The conversion feature of the Sep 2016 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion feature of the Sep 2016 Note. As of December 31, 2020, the remaining balance on the Sep 2016 Note was $430,896, which is short term. The Company issued two (2) unsecured convertible promissory notes (the “Apr & May 2018 Notes”), in the aggregate amount of $300,000 on April 2, 2018 and May 31, 2018. The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion. The conversion feature of the Apr & May 2018 Notes was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Notes. During the nine months ended September 30, 2019, the Company issued 12,500 shares of common stock upon conversion of principal in the amount of $6,523, plus accrued interest of $4,727, with a fair value loss on conversion of $16,250. On March 13, 2019, the Company entered into a settlement agreement with the investor in the amount of $570,000, based on the outstanding balance due and payable under the Apr & May 2018 Notes. The Company set up a reserve of 2,630,769 shares of common stock of the Company for issuance upon conversion by the investor of the amounts owed under the Notes, in accordance with the terms of the Notes, including, but not limited to the beneficial ownership limitations contained in the Notes. In addition to the foregoing, upon the sale by the investor of the settlement shares as delivered to the investor by the Company, resulting in total net proceeds less than the settlement value, the investor is entitled to additional settlement shares of the Company’s common stock. If after the investor has sold all settlement shares, the investor delivers a written notice to the Company certifying that the investor is entitled to additional settlement shares of the Company’s common stock (the “Make-Whole Shares”). The number of make-whole shares being equal to the greater of ((i) zero and (ii) the quotient of (1) the difference of (x) the settlement value with respect to each sale of shares by the Investor after the delivery of the Settlement Shares, minus (y) the aggregate net consideration received by the Investor from the resale of all shares of common stock issued by the Company, divided by (2) the average trailing closing price for ten (10) trading days for the shares immediately preceding the date of delivery of the make-whole shares. During the year ended December 31, 2020, the Company issued 11,407,847 shares of common stock upon conversion of principal in the amount of $42,712, plus default settlement fees of $205,604. As of December 31, 2020, the remaining balance on the May 2018 Note was $218,064, which is short term. The Company entered into an unsecured convertible promissory note (the “Oct 20 Note”), on October 2, 2020 in the amount of $5,000. The Company received additional funds in the aggregate amount of $15,000. The Oct 2 Note matures on October 2, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Oct 2 Note bears interest at 10% per year. The Oct 2 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Oct 2 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended the Company paid off the $20,000 in cash, of the Oct 2 Note. As of December 31, 2020, the remaining balance of the Oct 2 Note was $0. The Company entered into an unsecured convertible promissory note (the “Nov 20 Note”), on November 19, 2020 in the amount of $50,000. The Company received funds in the amount of $50,000. The Nov 20 Note matures on November 19, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended the Company paid off $21,000 in cash, of the Nov 20 Note. As of December 31, 2020, the remaining balance of the Nov 20 Note was $29,000, which is short term. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory notes was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations. The derivative liability recognized in the financial statements as of December 31, 2020 was $12,310,307.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	12 Months Ended
	Dec. 31, 2020
Revenue From Contracts With Customers [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	6. REVENUE FROM CONTRACTS WITH CUSTOMERS Equipment Contracts Revenues and related costs on equipment contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. The following table represents a disaggregation of revenue by type of good or service from contracts with customers for the year ended December 31, 2020 and 2019. Years Ended December 31, 2020 2019 Equipment Contracts $ 2,393,815 $ 2,130,625 Component Sales 1,441,251 959,080 Waste Water Treatment Systems - 291,156 Pump Stations 144,755 100,763 Services Sales 121,310 86,270 Licensing Fees 20,000 $ 4,101,131 $ 3,587,894 Revenue recognition for other sales arrangements, such as sales for components, service and licensing fees will remain materially consistent. Contract assets represents revenues recognized in excess of amounts billed on contracts in progress. Contract liabilities represents billings in excess of revenues recognized on contracts in progress. Assets and liabilities related to long-term contracts are included in current assets and current liabilities in the accompanying balance sheets, as they will be liquidated in the normal course of the contract completion. The contract asset for the years ending December 31, 2020 and 2019, was $148,734 and $26,287, respectively. The contract liability for the years ended December 31, 2020 and 2019, was $340,551 and $428,009, respectively.

Financial Assets

Financial Assets	12 Months Ended
	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
FINANCIAL ASSETS	7. FINANCIAL ASSETS Convertible Note Receivable The Company purchased a 10% convertible note in the amount of $80,000, through a private placement with Water Technologies International, Inc (“WTII”). The Note is convertible into common stock of WTII at a price of 65% of the lowest trading price for the ten (10) trading days immediately prior to the conversion date. The conversion price shall not be lower than a price of $0.0001 per share. As of December 31, 2020, the note included principal of $80,000 plus accrued interest of $16,000 for a total of $133,879. The Note was considered impaired as of December 31, 2020, and an allowance was recognized in the financials in the amount of $133,879. Fair value investment in Securities On May 15, 2018, the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality was delivered immediately, the revenue was recognized in the financial statements as of June 30, 2018. As of December 31, 2020, the fair value of the preferred shares was $8,000.

Loans Payable

Loans Payable	12 Months Ended
	Dec. 31, 2020
Loans Payable Disclosure [Abstract]
LOANS PAYABLE	8. LOANS PAYABLE Secured Loans Payable The Company entered into short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2019, the finance cost was fully amortized. The term of the loans ranged from two months to six months. The net balance as of December 31, 2020 and 2019 was $342,896 and $427,214, respectively. Loan Payable-Related Party The Company’s CEO loaned the Company $248,870 as of June 28, 2018. The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates. The funds were used for operating expenses. During the period ended December 31, 2020, principal payments were made in the amount of $92,171 and the Company recorded interest of $21,019, leaving a balance of $94,883 as of December 31, 2020. Paycheck Protection Program Loan Between May 4, 2020 and May 5, 2020, the Company received loan proceeds in the aggregate amount of $505,000 (the “PPP Loan”) under the Paycheck Protection Program (the “PPP”) under the Coronavirus Aid, Relief and Economic Security Act. The principal and accrued interest under the Note is forgivable if the Company uses the PPP Loan proceeds for eligible purposes, including payroll, benefits, rent and utilities, and otherwise complies with PPP requirements. In order to obtain forgiveness of the PPP Loan, the Company must submit a request and provide satisfactory documentation regarding its compliance with applicable requirements. The Company must repay any unforgiven principal amount of the Note, with interest, on a monthly basis following the deferral period. The Company used the proceeds of the PPP Loan specifically for eligible purposes and will pursue forgiveness, although no assurance is provided that forgiveness for all or any portion of the PPP Loan will be obtained.

Capital Leases

Capital Leases	12 Months Ended
	Dec. 31, 2020
Capital Leases [Abstract]
CAPITAL LEASES	9. CAPITAL LEASES The Company entered into a capital lease for the purchase of equipment during the year ended December 31, 2019. The lease is for a sixty (60) month term, with monthly payments of $757 per month, and a purchase option at the end of the lease for $1.00. As of December 31, 2020, the maturities are summarized as follows: Capital lease $ 17,073 Less current portion 9,088 Total long-term liabilities $ 7,985 Long term maturities for the next two years are as follows: Period Ending December 31, 2021 9,088 2022 7,985 $ 17,073

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which significantly changed U.S. tax law. The Act lowered the Company’s U.S. statutory federal income tax rate from 35% to 21% effective January 1, 2018. The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2016. Included in the balance at December 31, 2020, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2020 and 2019, the Company did not recognize interest and penalties. At December 31, 2020, the Company had net operating loss carry-forwards of approximately $46,795,341, which expire at dates that have not been determined. No tax benefit has been reported in the December 31, 2020 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2020 and 2019 due to the following: 2020 2019 Book income (loss) $ 2,784,887 $ (5,764,730 ) Tax to book differences for deductible expenses 9,574 11,360 Tax non-deductible expenses (3,845,607 ) 4,870,700 Valuation Allowance 1,051,146 882,680 Income tax expense $ - $ - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax liabilities consist of the following components as of December 31, 2020 2019 Deferred tax assets: NOL carryover $ 9,827,022 $ 8,778,350 Other carryovers 749,475 728,905 Deferred tax liabilities: Depreciation (102,841 ) (73,755 ) Less Valuation Allowance (10,473,656 (9,433,500 ) Net deferred tax asset $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.

Foreign Subsidiary

Foreign Subsidiary	12 Months Ended
	Dec. 31, 2020
Foreign Subsidiary [Abstract]
FOREIGN SUBSIDIARY	11. FOREIGN SUBSIDIARY On December 31, 2014, the Company formed a wholly owned subsidiary, OriginClear Technologies Limited (OTG), in Hong Kong, China. The Company granted OTG a master license for the People’s Republic of China. In turn, OTG is expected to license regional joint ventures for water treatment.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	12. COMMITMENTS AND CONTINGENCIES Facility Rental – Related Party The Company rents from its subsidiary on a month-to-month basis a 12,000 square foot facility in McKinney, Texas at a base rent of $7,000 per month. Warranty Reserve Generally, a PWT project is guaranteed against defects in material and workmanship for one year from the date of completion, while certain areas of construction and materials may have guarantees extending beyond one year. The Company has various insurance policies relating to the guarantee of completed work, which in the opinion of management will adequately cover any potential claims. A warranty reserve has been provided under PWT based on the opinion of management and based on Company history in the amount of $20,000 for the year ending December 31, 2020. Litigation In February 2019, a Complaint was filed in the Superior Court for the State of California, for breach of contract, common law counts for sums due for services allegedly performed, and fraud. The Complaint was filed by RDI Financial, LLC (“RDI”), an alleged assignee of Interdependence, Inc., and named the Company and its developmental subsidiary, WaterChain, Inc., as Defendants. RDI claimed that its assignor, Interdependence, Inc., entered into a contract with the Defendants for Interdependence to provide reputation and professional relationship management services. RDI claimed that Interdependence provided the services and that the Company was required to make certain payments of cash and our capital stock to Interdependence, but did not do so. RDI claimed to be entitled to enforce the contract as the assignee, and demanded monetary damages in the aggregate amount of $630,000. The Company and WaterChain were unaware of the suit until September of 2019, when they received notice of a default judgment. Litigation counsel was engaged, and with the absence of prior notice or service of the suit, an improper default promptly challenged. In October 2019 the Court vacated the default and judgment, and granted the Company and WaterChain leave to file an Answer and Cross-Complaint against RDI and Interdependence. Through these filings, the Company and WaterChain, Inc. contested the allegations and claims in the Complaint, denied that Interdependence performed the required services, and contended that the Company overpaid Interdependence $40,000 for whatever limited work was done. More specifically, in November, 2019, an Answer was filed by the Company and WaterChain denying the claims in the Complaint, along with a Cross-Complaint alleging fraudulent inducement to enter into the contract, negligent misrepresentations, breach of contract, and to rescind the underlying contract. The Company alleged that Interdependence misrepresented the nature and scope of the services which were to be provided and its ability to provide them, falsely promised and promoted the results it would obtain for the Company and WaterChain in providing such services, and also failed to provide the Company with the services as required by the contract such that Interdependence was overpaid based on what limited work it in fact did. For those reasons, and prior to any litigation, the Company terminated the contract for non-performance. Following discovery and pleading activity, the Company and WaterChain entered into settlement negotiations with RDI to resolve this matter on a defense cost basis. The parties reached an amicable resolution and entered into a Settlement Agreement and Mutual and General Release on December 16, 2020 which provided for a less than defense cost resolution through a small payment of $20,000 and stock transfers on a monthly basis through December, 2021, with removal of restrictive legends occurring at six month intervals following each transfer. Notice of Settlement of Entire Case was filed with the Court in January, 2021, and all Court dates vacated. Once the stock transfers and restriction removals are completed, the action will be dismissed with prejudice. All parties are fully and timely performing under the Settlement Agreement, and no further issues or proceedings, or fees and costs, are anticipated. On January 12, 2021, OriginClear, Inc. Progressive Water Treatment, Inc. and T. Riggs Eckelberry, individually (collectively, the “ iKAHN Plaintiffs iKAHN iKAHN Agreement On April 22, 2021, the iKAHN Plaintiffs and iKAHN agreed to settle the dispute on the following terms: (i) vacatur of the judgment obtained by iKAHN against the iKAHN Plaintiffs; (ii) release of any and all bank levies, liens, security interests, powers of attorney, and other encumbrances iKAHN may have against the iKAHN Plaintiffs; and (iii) dismissal of the action filed by the iKAHN Plaintiffs against iKAHN with prejudice. Accordingly, the iKAHN Plaintiffs no longer owe any further amounts to iKAHN with respect to the iKAHN Agreement. On November 16, 2020, Progressive Water Treatment, Inc., OriginClear, Inc. and T. Riggs Eckelberry, individually (collectively, the “ Yellowstone Plaintiffs Yellowstone Yellowstone Agreement On December 4, 2020, Yellowstone filed a Motion to Dismiss the Yellowstone Plaintiffs’ Complaint. On January 5, 2021, Yellowstone’s Motion to Dismiss was granted. On January 5, 2021, the Yellowstone Plaintiffs filed a Notice of Appeal to the Court’s Decision & Order granting Yellowstone’s Motion to Dismiss, and will be submitting a memoranda of law in support in the near future. On October 12, 2020, OriginClear, Inc. Progressive Water Treatment, Inc. and T. Riggs Eckelberry, individually (collectively, the “ GTR Plaintiffs GTR GTR Agreements On October 16, 2020, the GTR Plaintiffs filed an Order to Show Cause seeking a Temporary Restraining Order and Preliminary Injunction. On October 23, 2020, the Court granted the GTR Plaintiffs’ request for a Temporary Restraining Order, which remains in effect as of the date hereof. On November 25, 2020, the GTR Plaintiffs filed an Amended Complaint, which included 1 defendant, Tzvi “Steve” Reich, the President and Manager of GTR (together with GTR, the “ GTR Defendants The GTR action is currently being litigated. On September 21, 2020, OriginClear, Inc. Progressive Water Treatment, Inc. and T. Riggs Eckelberry, individually (collectively, the “ C6 Plaintiffs C6 Capital C6 Agreement On March 12, 2021, the C6 Plaintiffs and C6 Capital agreed to settle the dispute on the following terms: (i) vacatur of the judgment obtained by C6 Capital against the C6 Plaintiffs; (ii) release of any and all bank levies, liens, security interests, powers of attorney, and other encumbrances C6 Capital may have against the C6 Plaintiffs; and (iii) dismissal of the action filed by the C6 Plaintiffs against C6 Capital with prejudice. Accordingly, the C6 Plaintiffs no longer owe any further amounts to C6 Capital with respect to the C6 Agreement. Furthermore, the sister-state judgment C6 Capital obtained against the C6 Plaintiffs in California is currently in the process of being vacated by stipulation. On September 18, 2019, Expansion Capital Group, LLC (“ Expansion Expansion Defendants Business Loan On December 30, 2019, Expansion and the Expansion Defendants entered into a Settlement Agreement (the “ Expansion Settlement The Expansion Defendants have retained legal counsel who will assert that the Business Loan and the Expansion Settlement are usurious transactions that should be declared and unenforceable against the Expansion Defendants. On February 12, 2019, Auctus Fund, LLC (“ Auctus On March 13, 2019, Auctus and OriginClear entered into a Settlement Agreement and Mutual General Release, under which Auctus would be permitted to convert $570,000 into OriginClear securities pursuant to the terms set forth in the convertible promissory notes. On February 2, 2021, OriginClear filed a Motion to Set Aside the Settlement Agreement as Void under Section 29(b) of the Securities Exchange Act of 1934 (the “ Act As of the date hereof, the Motion to Set Aside the Settlement Agreement has been fully briefed by the parties to the action; however, United States District Court for the District of Massachusetts has not yet established a schedule or issued a decision.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2020
Risks and Uncertainties [Abstract]
CONCENTRATIONS	13. CONCENTRATIONS Major Customers PWT had two major customers for the year ended December 31, 2020. The customers represented 34% of billings for the year ending December 31, 2020. The contract receivable balance for the customers was $149,070 at December 31, 2020. PWT had four major customers for the year ended December 31, 2019. The customers represented 56% of billings for the year ending December 31, 2019. The contract receivable balance for the customers was $174,803 at December 31, 2019. Major Suppliers PWT had three major vendors for the year ended December 31, 2020. The vendors represented 45.2% of total expenses in the year ending December 31, 2020. The accounts payable balance due to the vendors was $170,963 at December 31, 2020. Management believes no risk is present with the vendors due to other suppliers being readily available. PWT had three major vendors for the year ended December 31, 2019. The vendors represented 36.34% of total expenses in the year ending December 31, 2019. The accounts payable balance due to the vendors was $198,733 at December 31, 2019. Management believes no risk is present with the vendors due to other suppliers being readily available.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	14. SUBSEQUENT EVENTS Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: Between January 4, 2021 and March 15, 2021, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs Eckelberry, one employee and one consultant an aggregate of 2,003,875 shares of the Company’s common stock. Between January 5, 2021 and February 5, 2021, holders of convertible promissory notes converted an aggregate principal and interest amount of $61,007 into an aggregate of 6,354,895 shares of the Company’s common stock. Between January 6, 2021 and March 15, 2021, the Company sold an aggregate of 1,471 shares of the Company’s Series M preferred stock for an aggregate purchase price of $29,425. Between January 7, 2021 and May 10, 2021, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 2,396 shares of the Company’s Series R preferred stock for an aggregate purchase price of $2,395,750. The Company also issued an aggregate of 47,915,000 Series A warrants and 9,125,000 Series B warrants to the investors. Between January 28, 2021 and April 30, 2021, the Company issued to consultants and one employee an aggregate of 9,894,429 shares of the Company’s common stock for services including an aggregate of 698,328 shares of common stock for settlement of prior consulting agreement. Between February 11, 2021 and April 20, 2021, holders of Series J Preferred Stock converted an aggregate of 37.5 Series J shares into an aggregate of 1,097,991 shares, including make-good shares, of the Company’s common stock. Between January 5, 2021 and April 20, 2021, holders of Series L Preferred Stock converted an aggregate of 465 Series L shares into an aggregate of 15,966,567 shares, including make-good shares, of the Company’s common stock. Between January 13, 2021 and April 20, 2021, holders of Series O Preferred Stock converted an aggregate of 915 Series O shares into an aggregate of 23,879,570 shares of the Company’s common stock. Between January 8, 2021 and April 20, 2021, holders of Series P Preferred Stock converted an aggregate of 234 Series P shares into an aggregate of 8,182,992 shares, including make-good shares, of the Company’s common stock. Between January 8, 2021 and April 20, 2021, holders of Series Q Preferred Stock converted an aggregate of 160 Series Q shares into an aggregate of 4,120,832 shares of the Company’s common stock. Between January 20, 2021 and April 20, 2021, holders of Series R Preferred Stock converted an aggregate of 451 Series R shares into an aggregate of 13,478,690 shares, including make-good shares, of the Company’s common stock. Between February 11, 2021 and April 20, 2021, holders of Series S Preferred Stock converted an aggregate of 50 Series S shares into an aggregate of 1,269,302 shares of the Company’s common stock. Between February 10 and April 15, 2021, the Company entered into exchange agreements with holders of the Company’s Series G Preferred Stock pursuant to which such holders exchanged an aggregate of 245 shares of Series G Preferred Stock for 245 shares of the Company’s Series S Preferred Stock. Between March 17, 2021 and April 15, 2021, the Company issued an aggregate of 1,769 shares of the Company’s Series R Preferred Stock in exchange for an aggregate of 232 shares of Series I Preferred Stock, an aggregate of 1,297 Series K Preferred Stock, an aggregate of 120 Series M Preferred Stock and an aggregate of 120 Series O Preferred Stock. On March 31, 2021, the Company issued an aggregate of 236,205 shares of the Company’s common stock as dividends to certain holders of Series O Preferred Stock. On April 15, 2021, the Company issued an aggregate of 68,571 shares of the Company’s common stock in exchange for Series D-1 preferred stock. On April 30, 2021, the Company was required to redeem 185 outstanding shares of Series G Preferred Stock but has not done so. On February 5, 2021, the Company filed a certificate of designation (the “Series S COD”) of Series S Preferred Stock (the “Series S”) with the Secretary of State of Nevada. Pursuant to the Series S COD, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S will not be entitled to any voting rights except as may be required by applicable law. The Series S will be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends On February 24, 2021, the Company filed a certificate of designation (the “Series T COD”) of Series T Preferred Stock (the “Series T”) with the Secretary of State of Nevada. Pursuant to the Series T COD, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T will not be entitled to any voting rights except as may be required by applicable law. The Series T will be convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. On March 1, 2021, the Company issued an aggregate of 630 shares of Series T Preferred Stock. On March 23, 2021, the Company filed a certificate of designation (the “Series U COD”) of Series U Preferred Stock (the “Series U”) with the Secretary of State of Nevada. Pursuant to the Series U COD, the Company designated 5,000 shares of preferred stock as Series U. The Series U a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly. The Series U will not be entitled to any voting rights except as may be required by applicable law. The Series U will be convertible into common stock of the Company in an amount determined by dividing 100% of the stated value of the Series U being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. On April 19, 2021, the Company filed a certificate of designation (the “Series V COD”) of Series V Preferred Stock (the “Series V”) with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 40,000 shares of preferred stock as Series V. The Series V Preferred Stock has a stated value of $500 per share, and will be entitled to an annual distribution of 25% of annual net profits of a newly established, Company wholly-owned subsidiary, Water On Demand, Inc., paid within 3 months of subsidiary’s accounting year-end. The Series V will not be entitled to any voting rights except as may be required by applicable law. The Series V will be convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series V Stock at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of Subsidiary’s annual net profits. On April 28, 2021, the Company filed a certificate of designation (the “Series W COD”) of Series W Preferred Stock (the “Series W”) with the Secretary of State of Nevada. Pursuant to the Series W COD, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W will not be entitled to any voting rights except as may be required by applicable law. The Series W will be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of OriginClear, Inc. and its wholly owned operating subsidiaries, Progressive Water Treatment, Inc., and OriginClear Technologies, Ltd. All material intercompany transactions have been eliminated upon consolidation of these entities.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Concentration Risk	Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2020, the cash balance in excess of the FDIC limits was $159,591. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk in these accounts.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates used to review the Company’s impairments and estimations of long-lived assets, revenue recognition on percentage of completion type contracts, allowances for uncollectible accounts, warranty reserves, inventory valuation, derivative liabilities and other conversion features, fair value investments, valuations of non-cash capital stock issuances and the valuation allowance on deferred tax assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Basic loss per share calculations are computed by dividing income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include securities or other contracts to issue common stock that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the years ended December 31, 2020 and 2019, respectively, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. For the Years Ended 2020 2019 Income (Loss) to common shareholders (Numerator) $ 13,261,365 $ (27,473,678 ) Basic weighted average number of common shares outstanding (Denominator) 20,651,668 2,170,270 Diluted weighted average number of common shares outstanding (Denominator) 312,352,351 2,170,270 Year ended December 31, 2020 The Company has included 15,800,000 warrants to purchase common shares, shares issuable from convertible debt of $3,100,503 and shares issuable from convertible preferred stock for the year ended December 31, 2020, because their impact on the earnings per share is dilutive. Year ended December 31, 2019 The Company has excluded 122,044 warrants, shares issuable from convertible debt of $3,432,300 and shares issuable from convertible preferred stock for the year ended December 31, 2019, because their impact on the loss per share is anti-dilutive.
Revenue Recognition	Revenue Recognition We recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. Revenues and related costs on construction contracts are recognized as the performance obligations for work are satisfied over time in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. Under ASC 606, revenue and associated profit, will be recognized as the customer obtains control of the goods and services promised in the contract (i.e., performance obligations). All un-allocable indirect costs and corporate general and administrative costs are charged to the periods as incurred. However, in the event a loss on a contract is foreseen, the Company will recognize the loss as it is determined. Revisions in cost and profit estimates during the course of the contract are reflected in the accounting period in which the facts for the revisions become known. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in job performance, job conditions, and estimated profitability, including those arising from contract penalty provisions, and final contract settlements, may result in revisions to costs and income, which are recognized in the period the revisions are determined. Contract receivables are recorded on contracts for amounts currently due based upon progress billings, as well as retention, which are collectible upon completion of the contracts. Accounts payable to material suppliers and subcontractors are recorded for amounts currently due based upon work completed or materials received, as are retention due subcontractors, which are payable upon completion of the contract. General and administrative expenses are charged to operations as incurred and are not allocated to contract costs.
Contract Receivable	Contract Receivable The Company bills its customers in accordance with contractual agreements. The agreements generally require billing to be on a progressive basis as work is completed. Credit is extended based on evaluation of clients financial condition and collateral is not required. The Company maintains an allowance for doubtful accounts for estimated losses that may arise if any customer is unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. The Company records an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts were $0 and $0 as of December 31, 2020 and 2019, respectively. The net contract receivable balance was $438,430 and $522,911 at December 31, 2020 and 2019, respectively.
Indefinite Lived Intangibles and Goodwill Assets	Indefinite Lived Intangibles and Goodwill Assets The Company accounts for business combinations under the acquisition method of accounting in accordance with ASC 805, “Business Combinations,” where the total purchase price is allocated to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. The purchase price is allocated using the information currently available, and may be adjusted, up to one year from acquisition date, after obtaining more information regarding, among other things, asset valuations, liabilities assumed and revisions to preliminary estimates. The purchase price in excess of the fair value of the tangible and identified intangible assets acquired less liabilities assumed is recognized as goodwill. The Company tests for indefinite lived intangibles and goodwill impairment in the fourth quarter of each year and whenever events or circumstances indicate that the carrying amount of the asset exceeds its fair value and may not be recoverable. In accordance with its policies, the Company performed a qualitative assessment of indefinite lived intangibles and goodwill at December 31, 2020 and 2019, and determined there was no impairment of indefinite lived intangibles and goodwill.
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $110,338 and $107,351 for the years ended December 31, 2020 and 2019, respectively.
Advertising Costs	Advertising Costs The Company expenses the cost of advertising and promotional materials when incurred. The advertising costs were $211,296 and $48,594 for the years ended December 31, 2020 and 2019, respectively.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Gain or loss is recognized upon disposal of property and equipment, and the asset and related accumulated depreciation are removed from the accounts. Expenditures for maintenance and repairs are charged to expense as incurred, while expenditures for addition and betterment are capitalized. Furniture and equipment are depreciated on the straight-line method and include the following categories: Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years December 31, 2020 2019 Machinery and Equipment $ 383,569 $ 193,570 Computer Equipment 62,854 59,468 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 409,988 Less accumulated depreciation (345,167 ) (292,919 ) Net Property and Equipment $ 258,206 $ 117,069 Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In the event that facts and circumstances indicate that the cost of any long-lived assets may be impaired, an evaluation of recoverability would be performed following generally accepted accounting principles. Depreciation expense during the year ended December 31, 2020 and 2019, was $52,247 and $43,369, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and for financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by the Financial Accounting Standards Board whereas the value of the award is measured on the date of grant and recognized over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the Financial Accounting Standards Board whereas the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Non-employee stock-based compensation charges generally are amortized over the vesting period on a straight-line basis. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice option pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2020, the balances reported for cash, contract receivables, cost in excess of billing, prepaid expenses, accounts payable, billing in excess of cost, and accrued expenses approximate the fair value because of their short maturities. We adopted ASC Topic 820 for financial instruments measured as fair value on a recurring basis. ASC Topic 820 defines fair value, established a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The following table presents certain investments and liabilities of the Company’s financial assets measured and recorded at fair value on the Company’s balance sheets on a recurring basis and their level within the fair value hierarchy as of December 31, 2020 and 2019. Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2020 $ 8,000 $ 8,000 $ - $ - Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ - Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2020 $ 12,310,307 $ - $ - $ 12,310,307 Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470 The following is a reconciliation of the derivative liability for which level 3 inputs were used in determining the approximate fair value: Balance as of January 1, 2019 $ 9,360,204 Loss on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 31,640,470 Fair Value of derivative liabilities issued 29,703 Loss on conversion of debt and change in derivative liability (19,359,866 ) Balance as of December 31, 2020 $ 12,310,307 For purpose of determining the fair market value of the derivative liability, the Company used Binomial lattice formula valuation model. The significant assumptions used in the Binomial lattice formula valuation of the derivative are as follows: 12/31/2020 12/31/2019 Risk free interest rate 0.08% - 0.13 % 1.48% - 1.69% Stock volatility factor 127.0% - 249.0 % 116.0% - 338.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None
Segment Reporting	Segment Reporting The Company’s business currently operates in one segment based upon the Company’s organizational structure and the way in which the operations are managed and evaluated.
Marketable Securities	Marketable Securities The Company adopted ASU 2016-01, “Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. It requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purpose, and separate presentation of financial assets and financial liabilities by measurement category and form of financial asset. It eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and determined that it had a significant impact on the condensed consolidated financial statements. The Company accounts for its investment in Water Technologies International, Inc. as available-for-sale securities, and the unrealized gain on the available-for-sale securities is recognized in net income.
Licensing agreement	Licensing agreement The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition. The licensing of the intellectual property (IP) is distinct from the non-license goods or services and has significant standalone functionality that provides a benefit or value. The functionality will not change during the license period due to the licensor’s activities. Because the significant standalone functionality is delivered immediately, the revenue is generally recognized when the license is delivered.
Reclassification	Reclassification Certain prior period accounts and balances have been reclassified to current period presentation for comparative purposes.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In February 2016, the FASB established ASC Topic 842, Leases (Topic 842), by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use (ROU) model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations. The Company adopted the new standard on January 1, 2019. The new standard provides a number of optional practical expedients in transition. The Company has elected the ‘package of practical expedients’, which permit it not to reassess under the new standard its prior conclusions about lease identification, lease classification and initial direct costs. The Company did not elect the use-of-hindsight or the practical expedient pertaining to land easements; the latter is not applicable to the Company. The new standard did not have a material impact on the Company’s audited consolidated financial statements. In August 2017, FASB issued accounting standards update ASU-2017-12, “D” (Topic 815) – “Targeted Improvements to Accounting for Hedging Activities”, to require an entity to present the earnings effect of the hedging instrument in the same statement line item in which the earnings effect of the hedged item is reported. The amendments in this update are effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods with the fiscal years beginning after December 15, 2020. Early adoption is permitted in any interim period after issuance of the update. The Company has evaluated the impact of the adoption of ASU 2017-12 on the Company’s audited consolidated financial statements, which had no material impact. In June 2018, FASB issued accounting standards update ASU 2018-07, (Topic 505) – “Shared-Based Payment Arrangements with Nonemployees”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees will be aligned with the requirements for share-based payments granted to employees. Under the ASU 2018-07, the measurement of equity-classified nonemployee share-based payments will be fixed on the grant date, as defined in ASC 718, and will use the term nonemployee vesting period, rather than requisite service period. The amendments in this update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted if financial statements have not yet been issued. The Company adopted ASU 2018-07 on the January 1, 2019. The adoption of the new standard did not have a material impact on the Company’s audited consolidated financial statements. Management reviewed currently issued pronouncements and does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the accompanying condensed financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Polices (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of loss per share anti-dilutive effect	For the Years Ended 2020 2019 Income (Loss) to common shareholders (Numerator) $ 13,261,365 $ (27,473,678 ) Basic weighted average number of common shares outstanding (Denominator) 20,651,668 2,170,270 Diluted weighted average number of common shares outstanding (Denominator) 312,352,351 2,170,270
Schedule of estimated useful life	Estimated Life Machinery and equipment 5-10 years Furniture, fixtures and computer equipment 5-7 years Vehicles 3-5 years Leasehold improvements 2-5 years
Schedule of property plant and equipment	December 31, 2020 2019 Machinery and Equipment $ 383,569 $ 193,570 Computer Equipment 62,854 59,468 Furniture 29,810 29,810 Leasehold Improvements 26,725 26,725 Vehicles 64,276 64,276 Demo Units 36,139 36,139 603,373 409,988 Less accumulated depreciation (345,167 ) (292,919 ) Net Property and Equipment $ 258,206 $ 117,069
Schedule of fair value of financial instruments	Total (Level 1) (Level 2) (Level 3) Investment at fair value-securities, December 31, 2020 $ 8,000 $ 8,000 $ - $ - Investment at fair value-securities, December 31, 2019 $ 9,600 $ 9,600 $ - $ -
Schedule of fair value of (liability) financial instruments	Total (Level 1) (Level 2) (Level 3) Derivative Liability, December 31, 2020 $ 12,310,307 $ - $ - $ 12,310,307 Derivative Liability, December 31, 2019 $ 31,640,470 $ - $ - $ 31,640,470
Schedule of reconciliation of the derivative liability for which level 3 inputs	Balance as of January 1, 2019 $ 9,360,204 Loss on conversion of debt and change in derivative liability 22,280,266 Balance as of December 31, 2019 31,640,470 Fair Value of derivative liabilities issued 29,703 Loss on conversion of debt and change in derivative liability (19,359,866 ) Balance as of December 31, 2020 $ 12,310,307
Schedule of fair market value of derivative liability assumptions	12/31/2020 12/31/2019 Risk free interest rate 0.08% - 0.13 % 1.48% - 1.69% Stock volatility factor 127.0% - 249.0 % 116.0% - 338.0% Weighted average expected option life 6 months - 5 years 6 months - 5 years Expected dividend yield None None

Options and Warrants (Tables)

Options and Warrants (Tables)	12 Months Ended
	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Schedule of warrant activity	2020 2019 Weighted Weighted Number average Number average of exercise of exercise Warrants price Warrants price Outstanding - beginning of year $ 122,044 $ 500.00 $ 125,456 $ 740 Granted 15,800,000 $ 0.03 - $ - Exercised $ - $ - Forfeited $ (3,412 ) $ 240 Outstanding - end of year 15,922,044 $ 500.03 $ 122,044 $ 500
Schedule of weighted average remaining contractual life of warrants outstanding	2020 2019 Weighted Weighted Remaining Remaining Exercisable Warrants Warrants Contractual Warrants Warrants Contractual Prices Outstanding Exercisable Life (years) Outstanding Exercisable Life (years) $ 0.05 9,800,000 - - - $ 0.10 6,000,000 $ 500.00 122,044 122,044 1.37 122,044 122,044 1.62 15,922,044 122,044 122,044

Convertible Promissory Notes (T

Convertible Promissory Notes (Tables)	12 Months Ended
	Dec. 31, 2020
Debt Disclosure [Abstract]
Schedule of outstanding convertible promissory notes	Convertible Promissory Notes $ 3,100,503 Less current portion 1,223,228 Total long-term liabilities $ 1,877,275
Schedule of maturities of long-term debt	Year Ending December 31, Amount 2021 1,241,158 2022 1,815,000 2023 62,275 $ 3,118,433

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	12 Months Ended
	Dec. 31, 2020
Revenue From Contracts With Customers [Abstract]
Schedule of disaggregation of revenue by type of good or service from contracts with customers	Years Ended December 31, 2020 2019 Equipment Contracts $ 2,393,815 $ 2,130,625 Component Sales 1,441,251 959,080 Waste Water Treatment Systems - 291,156 Pump Stations 144,755 100,763 Services Sales 121,310 86,270 Licensing Fees 20,000 $ 4,101,131 $ 3,587,894

Capital Leases (Tables)

Capital Leases (Tables)	12 Months Ended
	Dec. 31, 2020
Capital Leases [Abstract]
Schedule of maturities	Capital lease $ 17,073 Less current portion 9,088 Total long-term liabilities $ 7,985
Schedule of long term maturities	Period Ending December 31, 2021 9,088 2022 7,985 $ 17,073

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of income tax provision	2020 2019 Book income (loss) $ 2,784,887 $ (5,764,730 ) Tax to book differences for deductible expenses 9,574 11,360 Tax non-deductible expenses (3,845,607 ) 4,870,700 Valuation Allowance 1,051,146 882,680 Income tax expense $ - $ -
Schedule of net deferred tax liabilities	2020 2019 Deferred tax assets: NOL carryover $ 9,827,022 $ 8,778,350 Other carryovers 749,475 728,905 Deferred tax liabilities: Depreciation (102,841 ) (73,755 ) Less Valuation Allowance (10,473,656 (9,433,500 ) Net deferred tax asset $ - $ -

Organization and Line of Busi_2

Organization and Line of Business (Details) - USD ($)	Oct. 25, 2019	Dec. 31, 2020	Oct. 01, 2015
Organization and Line of Business (Details) [Line Items]
Revenue		$ 4,101,131
Reverse stock split, description	the Company effected a one-for-two thousand (1 for 2,000) reverse stock split of its common stock (the “Reverse Split”). All shares, options, warrants and per share information throughout these consolidated financial statements have been retroactively restated to reflect the Reverse Split.
Progressive Water Treatment, Inc. [Member]
Organization and Line of Business (Details) [Line Items]
Percentage of stock issued and outstanding acquired			100.00%

Summary of Significant Accoun_3

Summary of Significant Accounting Polices (Details) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Summary of Significant Accounting Polices (Details) [Line Items]
Restricted cash preferred shares	$ 159,591
Allowance for doubtful accounts	0	$ 0
Contract receivable	$ 438,430	522,911
Derivative term of contract	1 year
Total research and development costs	$ 110,338	107,351
Advertising costs	211,296	48,594
Depreciation expense	$ 52,247	$ 43,369
Warrant [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Antidilutive securities excluded from computation of earnings per share (in Shares)		122,044
Convertible Debt [Member]
Summary of Significant Accounting Polices (Details) [Line Items]
Common stock issuable (in Shares)	15,800,000
Convertible debt and preferred stock (in Shares)	3,100,503
Antidilutive securities excluded from computation of earnings per share (in Shares)		3,432,300

Summary of Significant Accoun_4

Summary of Significant Accounting Polices (Details) - Schedule of loss per share anti-dilutive effect - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Schedule of loss per share anti-dilutive effect [Abstract]
Income (Loss) to common shareholders (Numerator) (in Dollars)	$ 13,261,365	$ (27,473,678)
Basic weighted average number of common shares outstanding (Denominator)	20,651,668	2,170,270
Diluted weighted average number of common shares outstanding (Denominator)	312,352,351	2,170,270

Summary of Significant Accoun_5

Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life	12 Months Ended
	Dec. 31, 2020
Machinery and equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Machinery and equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	10 years
Furniture, fixtures and computer equipment [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Furniture, fixtures and computer equipment [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	7 years
Vehicles [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	3 years
Vehicles [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years
Leasehold improvements [Member] | Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	2 years
Leasehold improvements [Member] | Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of estimated useful life [Line Items]
Estimated Life	5 years

Summary of Significant Accoun_6

Summary of Significant Accounting Polices (Details) - Schedule of property plant and equipment - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 603,373	$ 409,988
Less accumulated depreciation	(345,167)	(292,919)
Net Property and Equipment	258,206	117,069
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	383,569	193,570
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	62,854	59,468
Furniture [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	29,810	29,810
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	26,725	26,725
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	64,276	64,276
Demo Units [Member]
Property, Plant and Equipment [Line Items]
Gross Property and Equipment	$ 36,139	$ 36,139

Summary of Significant Accoun_7

Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	$ 8,000	$ 9,600
Level 1 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities	8,000	9,600
Level 2 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities
Level 3 [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair value of financial instruments [Line Items]
Investment at fair value-securities

Summary of Significant Accoun_8

Summary of Significant Accounting Polices (Details) - Schedule of fair value of (liability) financial instruments - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	$ 12,310,307	$ 31,640,470
Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability
Level 2 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability
Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	$ 12,310,307	$ 31,640,470

Summary of Significant Accoun_9

Summary of Significant Accounting Polices (Details) - Schedule of reconciliation of the derivative liability for which level 3 inputs - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Schedule of reconciliation of the derivative liability for which level 3 inputs [Abstract]
Balance	$ 31,640,470	$ 9,360,204
Fair Value of derivative liabilities issued	29,703
Loss on conversion of debt and change in derivative liability	(19,359,866)	22,280,266
Balance	$ 12,310,307	$ 31,640,470

Summary of Significant Accou_10

Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Expected dividend yield	0.00%	0.00%
Minimum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	0.08%	1.48%
Stock volatility factor	127.00%	116.00%
Weighted average expected option life	6 months	6 months
Maximum [Member]
Summary of Significant Accounting Polices (Details) - Schedule of fair market value of derivative liability assumptions [Line Items]
Risk free interest rate	0.13%	1.69%
Stock volatility factor	249.00%	338.00%
Weighted average expected option life	5 years	5 years

Capital Stock (Details)

Capital Stock (Details) - USD ($)	Oct. 16, 2020	Aug. 21, 2020	Jun. 03, 2019	Apr. 03, 2019	Jan. 16, 2019	Aug. 14, 2018	Apr. 13, 2018	Mar. 14, 2017	Dec. 31, 2020	Dec. 31, 2019	Mar. 01, 2021	Apr. 23, 2019
Capital Stock (Details) [Line Items]
Value of closing stock price (in Dollars)									$ 23,778
Shares isssued									12,500		630
Preferred Stock, Convertible, Conversion Price, Increase (in Dollars per share)									$ 0.0999
Common stock, shares authorized									16,000,000,000	16,000,000,000		8,000,000,000
Common Stock [Member]
Capital Stock (Details) [Line Items]
Issuance of common stock, shares									32,482,536
Principal amount (in Dollars)									$ 19,276,917
Convertible interest value (in Dollars)									137,262
Settlement fees (in Dollars)									51,186
Fair value loss on settlement (in Dollars)									$ 204,402	$ 77,925
Shares issued for services									7,750,037
Fair value amount (in Dollars)									$ 415,036
Preferred stock dividends payable									688,205
Common stock for settlement of convertible promissory notes									6,603,479	2,647,017
Aggregate principal amount (in Dollars)										$ 535,035
Interest amount (in Dollars)										116,306
Debt conversion amount (in Dollars)										$ 102,527
Common stock issued for services, shares										1,070,855
Common stock issued for services, shares										706,262
Common Stock [Member] | Minimum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)									$ 0.00955	$ 0.05
Common Stock [Member] | Maximum [Member]
Capital Stock (Details) [Line Items]
Conversion price (in Dollars per share)									$ 0.0394	$ 1.84
Series C Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock, share authorized								1,000	550,000,000	550,000,000
Preferred stock, par value (in Dollars per share)								$ 0.0001	$ 0.0001	$ 0.0001
Voting power								51%
Preferred stock per share (in Dollars per share)								$ 0.0001
Purchase price of the Series C preferred stock (in Dollars per share)								$ 0.10
Total purchase price Series C preferred stock, shares								1,000
Preferred stock shares outstanding									1,000	1,000
Preferred stock issued									1,000	1,000
Series D-1 Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding									32,500,000
Designated preferred stock issued							50,000,000
Conversion price (in Dollars per share)							$ 0.0005
Issuance of common stock, shares							1		295,141
Conversion of shares									6,000,000
Preferred stock issued									32,500,000
Series E Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding									1,537,213	2,139,649
Designated preferred stock issued						4,000,000
Conversion price (in Dollars per share)						$ 0.05
Issuance of common stock, shares									30,124
Conversion of shares									602,436
Preferred stock issued									1,537,213	2,139,649
Series F Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding									275
Designated preferred stock issued						6,000
Preferred stock issued									275
Description of convertible preferred stock terms						The shares of Series F preferred stock have a liquidation preference equal to the stated value of $1,000 per share plus any accrued but unpaid dividends. The Series F preferred stock is not convertible into common stock. The holders of outstanding shares of Series F preferred stock are entitled to quarterly dividends at the annual rate of 8% of the stated value, in preference to any dividends on the common stock. The shares of Series F preferred stock do not carry any voting rights. The Company may, in its sole discretion, at any time while the Series F preferred stock is outstanding, redeem all or any portion of the outstanding Series preferred stock at a price equal to the stated value, plus any accrued but unpaid dividends. The Company was required to redeem all outstanding shares of Series F preferred stock on September 1, 2020.
Preferred stock, description									a holder of 100 of such outstanding shares of Series F preferred stock, agreed that the Company would have no obligation to redeem such holder’s shares of Series F preferred stock prior to September 1, 2022, and the Company agreed to pay such holder, in addition to any dividends payable on such holder’s Series F preferred stock, an annual fee of 4% of the stated value of such holder’s shares of Series F preferred stock. Excluding such 100 shares, as of December 31, 2020, the Company had 175 outstanding shares of Series F preferred stock which the Company was required to, and failed to redeem on September 1, 2020, and was in default for an aggregate redemption price (equal to the stated value) of $175,000.
Aggregate purchase price, shares									125,000
Aggregate preferred stock, share issued									1,278
Series G Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock shares outstanding									430
Issuance of common stock, shares										82,799
Preferred stock issued									430
Description of convertible preferred stock terms					the Company designated 6,000 shares as Series G preferred stock, each share having a stated value of $1,000 per share and holders of Series G preferred stock are entitled to cumulative dividends at the annual rate of 8% of the stated value, payable quarterly. The Series G preferred stock does not have voting rights, except as required by law and is not convertible into common stock. The Company may, in its sole discretion, at any time while the Series G preferred stock is outstanding, redeem all or any portion of the outstanding Series G preferred stock at a price equal to the stated value plus any accrued but unpaid dividends. The Company is required to redeem such shares of Series G preferred stock on April 30, 2021, at a price equal to the stated value plus any accrued but unpaid dividends. Pursuant to certain subscription agreements entered into with purchasers of the Series G preferred stock, each purchaser received shares of the Company’s common stock equal to an amount of, for each share of Series G preferred stock purchased, five hundred dollars ($500) divided by the closing price on the date the Company receives the executed subscription documents and purchase price from such investor. Between January 16, 2019 and March 20, 2019, the Company entered into subscription agreements with certain accredited investors pursuant to which the Company sold an aggregate of 530 shares of the Company’s Series G preferred stock for an aggregate purchase price of $530,000, which is recognized as a long-term liability.
Exchange Shares									100
Series I Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock shares outstanding									797	797
Designated preferred stock issued				4,000
Preferred stock issued									797	797
Dividend rate, percentage				8.00%
Purchase price (in Dollars)									$ 797,400
Series J Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)				$ 1,000
Preferred stock shares outstanding									273
Designated preferred stock issued									100,000
Issuance of common stock, shares									2,484,865	171,176
Conversion of shares									127
Common stock for settlement of convertible promissory notes										50
Series K Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock shares outstanding									3,160	2,001
Designated preferred stock issued			4,000
Preferred stock issued									3,160	2,001
Purchase price (in Dollars)									$ 1,159,767
Shares isssued									1,160
Series M Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)									$ 25
Designated preferred stock issued									800,000
Issuance of common stock, shares									137,052
Conversion of shares									320
Preferred stock issued									42,213
Dividend rate, percentage			8.00%						10.00%
Liquidation preference value (in Dollars)									$ 25
Redemption price (in Dollars)									$ 37.50
Stated value percentage									150.00%
Aggregate purchase price, shares									8,532
Aggregate value (in Dollars)									$ 213,300
Aggregate preferred stock, share issued									34,200
Convertible preferred stock, value issued (in Dollars)									$ 171,260
Series L Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)			$ 1,000
Preferred stock shares outstanding									1,132
Designated preferred stock issued			100,000
Issuance of common stock, shares									18,486,913
Conversion of shares									450
Preferred stock issued									1,132
Shares isssued									580
Series O Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)									$ 1,000
Designated preferred stock issued									2,000
Issuance of common stock, shares									1,995
Preferred stock issued									1,995
Description of convertible preferred stock terms									(i) in cash at an annual rate of 8% of the stated value, and (ii) in shares of common stock of the Company (valued based on the conversion price as in effect on the last trading day of the applicable fiscal quarter) at an annual rate of 4% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series O Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series O Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series O Preferred Stock. The Series O Preferred Stock does not have voting rights except as required by law. The Series O Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series O Preferred Stock being converted by the conversion price, provided that, the Series O may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price is equal to the average closing sale price of the common stock for the five trading days prior to the conversion date.
Aggregate purchase price, shares									1,775,000
Aggregate value (in Dollars)									$ 688,205
Percentage of common stock									4.00%
Series Q Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)		$ 1,000
Preferred stock shares outstanding									1,025
Designated preferred stock issued		2,000
Preferred stock issued									1,025
Dividend rate, percentage		12.00%
Aggregate preferred stock, share issued									1,278
Purchase price (in Dollars)									$ 200,000
Percentage of common stock									200.00%
Percentage Of common stock outstanding									4.99%
Description of common stock conversion basis									During the year ended December 31, 2020, 53 shares of Series Q preferred stock were converted into 3,140,140 shares of common stock. Also, there was a rollover from Series F preferred stock of 90 shares, plus a rollover from Series Q to Series O preferred stock for 200 shares.
Conversion of common stock (in Dollars)									$ 5,226
Series P Preferred Stocks Member
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)									$ 1,000
Preferred stock shares outstanding									357
Designated preferred stock issued									500
Preferred stock issued									357
Description of convertible preferred stock terms									During the year ended December 31, 2020, the Company issued 8,079,477 shares of common stock for conversion of 143 shares of Series P Preferred stock. As of December 31, 2020, there were 357 shares of Series P preferred stock issued and outstanding. Series Q On August 21, 2020, the Company designated 2,000 shares of preferred stock as Series Q Preferred Stock. The Series Q Preferred Stock has a stated value of $1,000 per share, and entitles holders to receive cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series Q Preferred Stock has a liquidation preference equal to the stated value plus any accrued but unpaid dividends, in preference to the common stock. The Series Q Preferred Stock has no preemptive or subscription rights, and there is no sinking fund provision applicable to the Series Q Preferred Stock. The Series Q Preferred Stock does not have voting rights except as required by law. The Series Q Preferred Stock is convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series Q Preferred Stock being converted by the conversion price, provided that, the Series Q may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series Q Preferred Stock at any time while the Series Q Preferred Stock are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends. The cumulative dividends are recorded as interest expense. During the year ended December 31, 2020, the Company issued an aggregate of 1,278 shares of Series Q Preferred Stock in exchange for 1,278 shares of Series F Preferred Stock. During the year ended December 31, 2020, 53 shares of Series Q preferred stock were converted into 3,140,140 shares of common stock. Also, there was a rollover from Series F preferred stock of 90 shares, plus a rollover from Series Q to Series O preferred stock for 200 shares. For the year ended December 31, 2020, the Company recognized a gain on conversion of Series Q preferred stock in the amount of $5,226.
Percentage of common stock									4.99%
Increased common stock percentage									9.99%
Series R Preferred Stock [Member]
Capital Stock (Details) [Line Items]
Preferred stock per share (in Dollars per share)	$ 1,000
Designated preferred stock issued	5,000
Issuance of common stock, shares									490
Dividend rate, percentage	10.00%
Purchase price (in Dollars)									$ 490,000
Shares isssued									490
Percentage of common stock									200.00%
Increased common stock percentage									9.99%
Percentage Of common stock outstanding									4.99%
Fair value (in Dollars)									$ 299,605
Amount of accrued dividends (in Dollars)									256,274
Series R Preferred Stock [Member] | Warrant A [Member]
Capital Stock (Details) [Line Items]
Preferred stock warrants (in Dollars)									9,800,000
Series R Preferred Stock [Member] | Series B warrant [Member]
Capital Stock (Details) [Line Items]
Preferred stock warrants (in Dollars)									$ 6,000,000

Options and Warrants (Details)

Options and Warrants (Details) - USD ($)	May 18, 2020	Aug. 14, 2019	Dec. 31, 2020	Dec. 31, 2019
Options and Warrants (Details) [Line Items]
Restricted stock grant agreement, description	the Company entered into Restricted Stock Grant Agreements (the “May RSGAs”) with its Chief Executive Officer, T. Riggs Eckelberry, members of the Board, employees and consultants to create management incentives to improve the economic performance of the Company and to increase its value and stock price. All shares issuable under the May RSGAs are performance-based shares and none have yet vested nor have any been issued. The May RSGAs provide for the issuance of up to an aggregate of 10,500,000 shares of the Company’s common stock as follows: 2,000,000 to Mr. Eckelberry, 500,000 to each of the other three members of the Board, and an aggregate of 7,000,000 to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period, the Company will issue up to an aggregate of 5,250,000 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 5,250,000 shares of its common stock. As the performance goals are achieved or if alternate vesting is qualified and selected, the shares shall become eligible for vesting and issuance.	The E&C RSGAs provide for the issuance of up to 378,750 shares of the Company’s common stock to employees and consultants provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 189,375 shares of its common stock; b) If the Company’s consolidated operating profit Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC reports, the Company will issue up to an aggregate of 189,375 shares of its common stock. As of December 31, 2019, an aggregate of 30,250 shares issuable under the E&C RSGAs have been cancelled. The Company has not recognized any costs associated with the milestones, because achievement is not probable. As the performance goals are achieved, the shares shall become eligible for vesting and issuance
Aggregate shares				30,250
Aggregate share			1,181,123
Aggregate value of common stock			$ 40,019
Cost vesting share amount			15,800,000
Warrants outstanding			$ 0
Restricted Stock Grant Agreement [Member] | Restricted Stock to Employees and Consultants [Member]
Options and Warrants (Details) [Line Items]
Restricted stock grant agreement, description		The RSGAs provides for the issuance of up to an aggregate of 109,214 shares of the Company’s common stock to Mr. Eckelberry provided certain milestones are met in certain stages; a) If the Company’s consolidated gross revenue, calculated in accordance with generally accepted accounting principles, consistently applied, equals or exceeds $15,000,000 for the trailing twelve month period as reported in the Company’s quarterly or annual financial statements, the Company will issue up to an aggregate of 54,607 shares of its common stock; b) If the Company’s consolidated operating profit (Operating Profit = Operating Revenue - Cost of Goods Sold - Operating Expenses - Depreciation & Amortization), calculated in accordance with generally accepted accounting principles, equals or exceeds $1,500,000 for the trailing twelve month period as reported as reported in the Company’s SEC Reports, the Company will issue up to an aggregate of 54,607 shares of its common stock.
Restricted Stock to Employees and Consultants [Member] | Restricted Stock Grant Agreement [Member]
Options and Warrants (Details) [Line Items]
Fair market value of stock grant, description		The Grantees can elect to participate in the alternate vesting schedule for grants received at least two years prior to the date requested. On the first day of each calendar month, an aggregate dollar amount of restricted stock equal to an aggregate of 5% of the total dollar amount of the Company’s common stock that traded during the prior calendar month, will vest, divided equally among all RSGAs and E&C RSGAs that have duly elected to participate in the alternate vesting schedule, with value based on the fair market value under the respective RSGAs and E&C RSGAs. The fair market value shall equal the average of the trailing ten (10) closing trade prices of the Company’s common stock on the last ten (10) trading days of the month immediately prior to the date of determination as quoted on the public securities trading market on which the Company’s common stock is then traded.

Options and Warrants (Details)

Options and Warrants (Details) - Schedule of warrant activity - $ / shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Schedule of warrant activity [Abstract]
Number of Warrants, Outstanding - beginning of period	122,044	125,456
Weighted average exercise price, Outstanding - beginning of period	$ 500	$ 740
Number of Warrants, Granted	15,800,000
Weighted average exercise price, Granted	$ 0.03
Number of Warrants, Exercised
Weighted average exercise price, Exercised
Number of Warrants, Forfeited		(3,412)
Weighted average exercise price, Forfeited		$ 240
Number of Warrants, Outstanding - end of period	15,922,044	122,044
Weighted average exercise price, Outstanding - end of period	$ 500.03	$ 500

Options and Warrants (Details_2

Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding - shares	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding [Line Items]
Warrants Outstanding	15,922,044	122,044
Warrants Exercisable		122,044
0.05 [Member]
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding [Line Items]
Warrants Outstanding	9,800,000
0.10 [Member]
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding [Line Items]
Warrants Outstanding	6,000,000
500.00 [Member]
Options and Warrants (Details) - Schedule of weighted average remaining contractual life of warrants outstanding [Line Items]
Warrants Outstanding	122,044	122,044
Warrants Exercisable	122,044	122,044
Weighted Average Remaining Contractual Life (years)	1 year 135 days	1 year 226 days

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Mar. 13, 2019	Nov. 19, 2020	Sep. 15, 2016	Dec. 31, 2020	Mar. 01, 2021	Oct. 02, 2020	Jun. 28, 2018	Apr. 02, 2018
Convertible Promissory Notes (Details) [Line Items]
Net balance							$ 248,870
Accrued interest				$ 4,727
Long term convertible note				1,223,228
Conversion of principal amount				5,150
Convertible notes in aggregate amount				$ 432,048
Share issued (in Shares)				12,500	630
Conversion of principal amount				$ 6,523
Conversion of fair value loss				$ 16,250
Investor amount	$ 570,000
Secured promissory note, description				The Company entered into an unsecured convertible promissory note (the “Oct 20 Note”), on October 2, 2020 in the amount of $5,000. The Company received additional funds in the aggregate amount of $15,000. The Oct 2 Note matures on October 2, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Oct 2 Note bears interest at 10% per year. The Oct 2 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Oct 2 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended the Company paid off the $20,000 in cash, of the Oct 2 Note. As of December 31, 2020, the remaining balance of the Oct 2 Note was $0.
Remaining debt amount				$ 29,000
Derivative liabilities				12,310,307
Convertible Promissory Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Debt discount				17,930
Net balance				3,100,503
Aggregate remaining amount				$ 1,011,150
Conversion price per share of debt, description				The 2014-2015 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $4,200 to $9,800 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2014-2015 Notes.
Number of shares converted into common stock (in Shares)				6,709,160
Converted an aggregate principal amount				$ 89,400
Accrued interest				51,186
Long term convertible note				615,000
Convertible Promissory Notes [Member] | Minimum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion prices from lesser				4,200
Convertible Promissory Notes [Member] | Maximum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion prices from lesser				9,800
Unsecured Convertible Promissory Notes One [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 0.10				$ 300,000
Conversion price per share of debt, description				The Apr & May 2018 Notes had maturity dates of April 2, 2019 and May 31, 2019, respectively. The Apr & May 2018 Notes bear interest at 10% per year. The Apr & May 2018 Notes may be converted into shares of the Company’s common stock at a variable conversion price of 50% of the lesser of the lowest trading price twenty-five (25) trading days prior to conversion.
Description of debt instrument				the Company issued 11,407,847 shares of common stock upon conversion of principal in the amount of $42,712, plus default settlement fees of $205,604. As of December 31, 2020, the remaining balance on the May 2018 Note was $218,064, which is short term.
Reserved shares (in Shares)	2,630,769
Proceeds from Unsecured Notes Payable		$ 50,000
OID Notes [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 184,124
Conversion price per share of debt, description				After the amendment, the conversion price changed to the lesser of $5,600 per share, or b) fifty percent (50%) of the lowest trade price of common stock recorded since the original effective date of this note, or c) the lowest effective price per share granted to any person or entity after the effective date.
Accrued interest				$ 13,334
OID Notes [Member] | Minimum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price of debt (in Dollars per share)				$ 1,400
OID Notes [Member] | Maximum [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price of debt (in Dollars per share)				$ 5,600
Convertible Debt [Member]
Convertible Promissory Notes (Details) [Line Items]
Aggregate remaining amount				$ 430,896
Conversion of accounts payable into a convertible note				$ 30,620
Percentage of average of lowest closing prices				75.00%
Convertible Debt One [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion of accounts payable into a convertible note			$ 430,896	$ 130,711
Short term convertible note				$ 167,048
Description of debt instrument			Note has zero stated interest rate, and the conversion price shall be equal to 75% of the average three lowest last sale prices traded during the 25 trading days immediately prior to conversion.
Unsecured Convertible Notes One [Member]
Convertible Promissory Notes (Details) [Line Items]
Conversion price per share of debt, description				The 2015-2016 Notes may be converted into shares of the Company’s common stock at conversion prices ranging from the lesser of $1,400 to $5,600 (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or 50% of the lowest trade price on any trade day following issuance of the 2015-2016 Notes.
Debt instrument interest rate				10.00%
Convertible promissory notes						$ 5,000
Aggregate amount						$ 15,000
Unsecured Convertible Notes Five [Member]
Convertible Promissory Notes (Details) [Line Items]
Converted an aggregate principal amount		$ 50,000
Unsecured Convertible Notes Two [Member]
Convertible Promissory Notes (Details) [Line Items]
Convertible promissory note, description		The Nov 20 Note matures on November 19, 2021, twelve months from the effective date of the Note. The Note may be extended sixty (60) months from the maturity date. The Nov 20 Note bears interest at 10% per year. The Nov 20 Note may be converted into shares of the Company’s common stock at a lesser price of $0.05 per share or (b) fifty percent (50%) of the lowest trade price of common stock recorded on any trade after the effective date, or (c) the lowest effective price per share granted. In addition, for each conversion, in event that shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $2,000 per day shall be assessed for each day after the third business day until the shares are delivered. The conversion feature of the Nov 20 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Note. During the year ended the Company paid off $21,000 in cash, of the Nov 20 Note.

Convertible Promissory Notes _2

Convertible Promissory Notes (Details) - Schedule of outstanding convertible promissory notes	Dec. 31, 2020USD ($)
Schedule of outstanding convertible promissory notes [Abstract]
Convertible Promissory Notes	$ 3,100,503
Less current portion	1,223,228
Total long-term liabilities	$ 1,877,275

Convertible Promissory Notes _3

Convertible Promissory Notes (Details) - Schedule of maturities of long-term debt	Dec. 31, 2020USD ($)
Schedule of maturities of long-term debt [Abstract]
2021	$ 1,241,158
2022	1,815,000
2024	62,275
Total	$ 3,118,433

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Revenue From Contracts With Customers [Abstract]
Contract assets	$ 148,734	$ 26,287
Contract liability	$ 340,551	$ 428,009

Revenue from Contracts with C_4

Revenue from Contracts with Customers (Details) - Schedule of disaggregation of revenue by type of good or service from contracts with customers - Type of Good or Service [Member] - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Equipment Contracts	$ 2,393,815	$ 2,130,625
Component Sales	1,441,251	959,080
Waste Water Treatment Systems		291,156
Pump Stations	144,755	100,763
Services Sales	121,310	86,270
Licensing Fees		20,000
Total	$ 4,101,131	$ 3,587,894

Financial Assets (Details)

Financial Assets (Details) - USD ($)	May 15, 2018	Dec. 31, 2020
Financial Assets (Details) [Line Items]
Convertible note total		$ 133,879
Convertible note recognized financial amount		133,879
Fair value investment in securities	the Company received 4,000 shares of WTII Series C convertible preferred stock for the use of OriginClear, Inc. technology associated with their proprietary electro water separation system. Each share of Series C convertible preferred stock is convertible into one thousand (1,000) shares of WTII common stock. The stock was valued at fair market value of $0.0075 for a price of $30,000 on the date of issuance. The Company analyzed the licensing agreement using ASU 606 to determine the timing of revenue recognition.
Preferred shares fair value		$ 8,000
Convertible Note Receivable [Member]
Financial Assets (Details) [Line Items]
Convertible note percentage		10.00%
Convertible note amount		$ 80,000
Convertible note price		65.00%
Number of trading days		10
Conversion price per share (in Dollars per share)		$ 0.0001
Convertible note principal amount		$ 80,000
Convertible note accrued interest		$ 16,000

Loans Payable (Details)

Loans Payable (Details) - USD ($)	May 05, 2020	Dec. 31, 2020	Dec. 31, 2019	Jun. 28, 2018
Loans Payable (Details) [Line Items]
Loan payable, net		$ 342,896	$ 427,214
Notes payable				$ 248,870
Principal amount		92,171
Payments balance		21,019
Leaving balance		$ 94,883
Loan Payable-Borrowings [Member]
Loans Payable (Details) [Line Items]
Maturity date, description		The loans bear interest at various rates to be repaid over a period of three (3) years at various maturity dates.
Proceeds from loans received	$ 505,000
Secured Loans Payable [Member]
Loans Payable (Details) [Line Items]
Leaving balance		short term loans with various lenders for capital expansion secured by the Company’s assets in the amount of $1,749,970, which included finance cost of $624,810. The finance cost was amortized over the terms of the loans, which have various maturity dates ranging from October 2018 through February 2019. As of December 31, 2019, the finance cost was fully amortized. The term of the loans ranged from two months to six months.

Capital Leases (Details)

Capital Leases (Details)	12 Months Ended
	Dec. 31, 2020USD ($)$ / shares
Disclosure Text Block [Abstract]
Capital lease term	60 months
Monthly payments for lease | $	$ 757
Lease price | $ / shares	$ 1

Capital Leases (Details) - Sche

Capital Leases (Details) - Schedule of maturities - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Schedule of maturities [Abstract]
Capital lease	$ 17,073
Less current portion	9,088	$ 9,088
Total long-term liabilities	$ 7,985

Capital Leases (Details) - Sc_2

Capital Leases (Details) - Schedule of long term maturities	Dec. 31, 2020USD ($)
Schedule of long term maturities [Abstract]
2021	$ 9,088
2022	7,985
Total	$ 17,073

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Jan. 01, 2018	Dec. 31, 2020
Income Taxes (Details) [Line Items]
U.S. statutory federal income tax rate	21.00%
Net operating loss carry-forwards (in Dollars)		$ 46,795,341
Maximum [Member]
Income Taxes (Details) [Line Items]
U.S. statutory federal income tax rate	35.00%

Income Taxes (Details) - Schedu

Income Taxes (Details) - Schedule of income tax provision - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Schedule of income tax provision [Abstract]
Book income (loss)	$ 2,784,887	$ (5,764,730)
Tax to book differences for deductible expenses	9,574	11,360
Tax non-deductible expenses	(3,845,607)	4,870,700
Valuation Allowance	1,051,146	882,680
Income tax expense

Income Taxes (Details) - Sche_2

Income Taxes (Details) - Schedule of net deferred tax liabilities - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Schedule of net deferred tax liabilities [Abstract]
NOL carryover	$ 9,827,022	$ 8,778,350
Other carryovers	749,475	728,905
Depreciation	(102,841)	(73,755)
Less Valuation Allowance	10,473,656	(9,433,500)
Net deferred tax asset

Commitments and Contingencies (

Commitments and Contingencies (Details)	1 Months Ended				9 Months Ended
	Dec. 16, 2020USD ($)	Dec. 30, 2019USD ($)	Mar. 13, 2019USD ($)	Jul. 09, 2018USD ($)	Sep. 30, 2020USD ($)m²	Dec. 31, 2020USD ($)	Mar. 20, 2019USD ($)	Feb. 28, 2019USD ($)	Dec. 13, 2018USD ($)	Nov. 07, 2018USD ($)	Nov. 06, 2018USD ($)
Commitments and Contingencies (Details) [Line Items]
Warrant reserve						$ 20,000
Aggregate amount demanding monetary damages								$ 630,000
Defence cost	$ 20,000
Amount of fees									$ 149,751
Expansion loan				$ 300,000
Repaid				$ 408,000
Expansion pay		$ 252,000
Monthly installments		$ 10,500
Installments period		24 months
Convertible promissory note			$ 570,000
iKAHN Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Amount of fees											$ 30,205
Yellowstone Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Amount of fees										$ 99,303
GTR Agreements [Member]
Commitments and Contingencies (Details) [Line Items]
Amount of fees							$ 143,083
C6 Agreement [Member]
Commitments and Contingencies (Details) [Line Items]
Amount of fees										$ 64,337
Mckinney [Member]
Commitments and Contingencies (Details) [Line Items]
Area of land (in Square Meters) | m²					12,000
Base rent					$ 7,000
Services amount overpaid								$ 40,000

Concentrations (Details)

Concentrations (Details)	12 Months Ended
	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Customers [Member]
Concentrations (Details) [Line Items]
Number of customers	2	4
Percentage of billings	34.00%	56.00%
Contract receivable (in Dollars)	$ 149,070	$ 174,803
Suppliers [Member]
Concentrations (Details) [Line Items]
Number of suppliers	3	3
Percentage of total expenses	45.20%	36.34%
Accounts payable (in Dollars)	$ 170,963	$ 198,733

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)

Feb. 05, 2021

Apr. 30, 2021

Apr. 28, 2021

Apr. 19, 2021

Mar. 23, 2021

Feb. 24, 2021

Feb. 05, 2021

Apr. 20, 2021

Apr. 15, 2021

Mar. 15, 2021

Mar. 15, 2021

Feb. 20, 2021

Apr. 20, 2021

Apr. 15, 2021

May 10, 2021

Apr. 20, 2021

Jun. 20, 2021

Dec. 31, 2020

Mar. 31, 2021

Mar. 01, 2021

Dec. 31, 2019

Subsequent Events (Details) [Line Items]

Subsequent event, description

the Company filed a certificate of designation (the “Series U COD”) of Series U Preferred Stock (the “Series U”) with the Secretary of State of Nevada. Pursuant to the Series U COD, the Company designated 5,000 shares of preferred stock as Series U. The Series U a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 10% of the stated value, payable quarterly. The Series U will not be entitled to any voting rights except as may be required by applicable law. The Series U will be convertible into common stock of the Company in an amount determined by dividing 100% of the stated value of the Series U being converted by the conversion price; certain prior investors will also be entitled to certain make-good shares; provided that, the Series U may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock. The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series U at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid dividends, or, if paid in shares of common stock, in an amount of shares determined by dividing the stated value being redeemed by the conversion price. On April 19, 2021, the Company filed a certificate of designation (the “Series V COD”) of Series V Preferred Stock (the “Series V”) with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 40,000 shares of preferred stock as Series V. The Series V Preferred Stock has a stated value of $500 per share, and will be entitled to an annual distribution of 25% of annual net profits of a newly established, Company wholly-owned subsidiary, Water On Demand, Inc., paid within 3 months of subsidiary’s accounting year-end. The Series V will not be entitled to any voting rights except as may be required by applicable law. The Series V will be convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series V Stock at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of Subsidiary’s annual net profits. On April 28, 2021, the Company filed a certificate of designation (the “Series W COD”) of Series W Preferred Stock (the “Series W”) with the Secretary of State of Nevada. Pursuant to the Series W COD, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W will not be entitled to any voting rights except as may be required by applicable law. The Series W will be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date.

Shares issued

12,500

630

Aggregate shares

30,250

Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Subsequent event, description

the Company filed a certificate of designation (the “Series W COD”) of Series W Preferred Stock (the “Series W”) with the Secretary of State of Nevada. Pursuant to the Series W COD, the Company designated 3,390 shares of preferred stock as Series W. The Series W has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly. The Series W will not be entitled to any voting rights except as may be required by applicable law. The Series W will be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series W being converted by the conversion price; provided that, the Series W may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series W at any time at a redemption price equal to the stated value plus any accrued but unpaid dividends.

Pursuant to the Series T COD, the Company designated 630 shares of preferred stock as Series T. The Series T has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 10% of the stated value, payable monthly. The Series T will not be entitled to any voting rights except as may be required by applicable law. The Series T will be convertible into common stock of the Company pursuant to the Series T COD, provided that, the Series T may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series T at any time while the Series T are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends.

Designation of shares description

Pursuant to the Series S COD, the Company designated 430 shares of preferred stock as Series S. The Series S has a stated value of $1,000 per share, and will be entitled to cumulative dividends in cash at an annual rate of 12% of the stated value, payable quarterly within 60 days from the end of such fiscal quarter. The Series S will not be entitled to any voting rights except as may be required by applicable law. The Series S will be convertible into common stock of the Company in an amount determined by dividing 200% of the stated value of the Series S being converted by the conversion price, provided that, the Series S may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The conversion price will be equal to the average closing sale price of the common stock for the five trading days prior to the conversion date. The Company will have the right (but no obligation) to redeem the Series S at any time while the Series S are outstanding at a redemption price equal to the stated value plus any accrued but unpaid dividends

Restricted Stock Grant Agreement [Member] | Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Subsequent event, description

Between January 4, 2021 and March 15, 2021, per electing and qualifying for the Restricted Stock Grant Agreement alternate vesting schedule, the Company issued to Mr. T. Riggs Eckelberry, one employee and one consultant an aggregate of 2,003,875 shares of the Company’s common stock.

Convertible Promissory Notes [Member] | Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Aggregate principal and interest amount (in Dollars)

$ 61,007

Aggregate shares of common stock

6,354,895

Forecast [Member]

Subsequent Events (Details) [Line Items]

Subsequent event, description

the Company filed a certificate of designation (the “Series V COD”) of Series V Preferred Stock (the “Series V”) with the Secretary of State of Nevada. Pursuant to the Series V COD, the Company designated 40,000 shares of preferred stock as Series V. The Series V Preferred Stock has a stated value of $500 per share, and will be entitled to an annual distribution of 25% of annual net profits of a newly established, Company wholly-owned subsidiary, Water On Demand, Inc., paid within 3 months of subsidiary’s accounting year-end. The Series V will not be entitled to any voting rights except as may be required by applicable law. The Series V will be convertible into common stock of the Company pursuant to the Series V COD, provided that, the Series V may not be converted into common stock to the extent such conversion would result in the holder beneficially owning more than 4.99% of the Company’s outstanding common stock (which may be increased up to 9.99% upon 61 days’ written notice). The Company will have the right (but no obligation) to redeem the Series V Stock at any time at a redemption price equal to, if paid in cash, the stated value plus any accrued but unpaid distributions of 25% of Subsidiary’s annual net profits.

Forecast [Member] | Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

698,328

698,328

Forecast [Member] | Consultants And One Employee [Member]

Subsequent Events (Details) [Line Items]

Shares issued to consultants and one employee

9,894,429

Series M Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

1,471

Aggregate purchase price (in Dollars)

$ 29,425

Series M Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

120

120

Series R Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Shares issued

490

Series R Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

13,478,690

Aggregate purchase price (in Dollars)

$ 2,395,750

Sale of Stock, Number of Shares Issued in Transaction

2,396

Aggregate shares

1,769

1,769

Aggregate converted shares

451

Series A Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Shares issued

47,915,000

Series B warrant [Member]

Subsequent Events (Details) [Line Items]

Shares issued

9,125,000

Series J Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate converted shares

127

Series J Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

1,097,991

Aggregate converted shares

37.5

Series L Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Shares issued

580

Aggregate converted shares

450

Series L Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

15,966,567

Aggregate converted shares

465

Series O Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Sale of Stock, Number of Shares Issued in Transaction

1,775,000

Series O Preferred Stock [Member] | Subsequent Event [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

236,205

Series O Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

23,879,570

Aggregate shares

120

120

Aggregate converted shares

915

Series P Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

8,182,992

Aggregate converted shares

234

Series Q Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Aggregate purchase price (in Dollars)

$ 200,000

Series Q Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

4,120,832

Aggregate converted shares

160

Series S Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

1,269,302

245

Aggregate converted shares

50

Series G Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares of common stock

245

Redemption of outstanding shares

185

Series I Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

232

232

Series K Preferred Stock [Member]

Subsequent Events (Details) [Line Items]

Shares issued

1,160

Series K Preferred Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

1,297

1,297

Series D-1 Preffered Stock [Member] | Forecast [Member]

Subsequent Events (Details) [Line Items]

Aggregate shares

68,571

68,571